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 ABSTRACT 
Vibrio anguillarum is an extracellular bacterial pathogen that is a causative agent 
of vibriosis in finfish and crustaceans. Mortality rates range from 30% to 100% and 
systemic infection usually causes fish to die within 1-4 days of initial infection. The 
primary routes of infections are through the skin, gills and intestines. Chemotactic 
motility and the metalloprotease EmpA have been shown to be important virulence 
factors during the invasion stage while the siderophore anguibactin, flagellin subunits and 
lipopolysaccharides were shown to be important for persistence in the host during the 
post-invasion stage. Three secreted proteins that are cytotoxic against epithelial cells and 
erythrocytes have been characterized in V. anguillarum: the HlyA homolog Vah1, the 
phospholipase Plp, and the MARTX toxin RtxA. Previous research has demonstrated that 
mutations in vah1 and/or plp resulted in slight attenuation against juvenile Atlantic 
salmon (Salmo salar); however, rtxA mutants were avirulent. Expression of the 
cytotoxins are under control of the transcriptional activator HlyU and the repressor H-NS. 
Additionally, a V. anguillarum hns mutant showed attenuation in virulence when injected 
intraperitoneally, suggesting that proper coordination of gene expression is an important 
factor during the post-invasion stage. 
In manuscript I “Isocitrate dehydrogenase mutation in Vibrio anguillarum results 
in virulence attenuation and immunoprotection in rainbow trout (Oncorhynchus mykiss)”, 
seven central metabolism mutants were created in the M93Sm strain and characterized 
with regard to growth in minimal and complex media, expression of virulence genes and 
virulence in juvenile rainbow trout. Only the isocitrate dehydrogenase (icd) mutant was 
attenuated in virulence against rainbow trout challenged by either intraperitoneal 
 injection or immersion. Further, the icd mutant was shown to be immunoprotective 
against wild type V. anguillarum experimental challenge. The icd mutant did not 
demonstrate a significant decrease in the expression of the three hemolysin genes was 
detected by qRT-PCR. Only the icd mutant exhibited a significantly decreased growth 
yield in complex media that was directly related to the amount of glutamate. A strain with 
a restored wild type icd gene was created and shown to restore growth to a wild type cell 
density in complex and minimal media and pathogenicity in rainbow trout. The data 
strongly suggest that a decreased growth yield, resulting from the inability to synthesize 
α-ketoglutarate derivatives (glutamate and glutamine), caused the attenuation despite 
normal levels of expression of virulence genes. Therefore, the ability of an extracellular 
pathogen to cause disease may be dependent upon the availability of host-supplied 
nutrients for growth.  
In manuscript II “Characterization of the growth and virulence of a Vibrio 
anguillarum citrate synthase mutant”, the role of glutamate auxotrophy during V. 
anguillarum M93Sm infection was further characterized. A citrate synthase (gltA) 
deletion mutant was created and characterized with regard to growth in minimal and 
complex media, expression of virulence genes, and virulence in juvenile rainbow trout. 
The ΔgltA mutant exhibited a decreased final cell density when grown in LB20 that 
resulted from the exhaustion of glutamate from the media. There was no significant 
decrease in the expression of the three hemolysin genes by the ΔgltA mutant when 
detected by qRT-PCR or mortality during challenge experiments. A ΔgltA mutant 
capable of growing in minimal media was isolated and shown to have a spontaneous 
mutation in the transcriptional activator of 2-methylcitrate synthase (prpR). This mutation 
 resulted in an increase in expression of 2-methylcitrate synthase (prpC). The ΔgltA 
prpR(R66L) mutant was characterized with regard to growth in complex media and 
exhibited a growth advantage compared to the ΔgltA mutant after 24 h in spleen extract 
medium. Further, after growing 120 h in spleen extract medium, colonies of ΔgltA 
mutants were shown to be capable of growing in minimal media. ΔprpC and a ΔgltA 
ΔprpC mutants were created and characterized with regard to growth in minimal and 
complex media and virulence in juvenile rainbow trout. The ΔgltA ΔprpC mutant had no 
growth advantage in spleen extract medium compared to the ΔgltA but was still as 
virulent as the wild type against rainbow trout. As expected, the ΔprpC mutant was 
similar to the wild type in regards to both growth in minimal and complex media and 
virulence against rainbow trout. The data strongly suggests that simple starvation for α-
ketoglutarate derivatives (glutamate and glutamine) is not directly linked to attenuation of 
virulence as previously proposed. Additionally, spontaneous mutations can occur that 
compensate for the original gene deletion if the new mutation can replace or bypass the 
lost metabolic reaction and results in a growth advantage. 
In manuscript III “Characterization of Vibrio anguillarum NB10Sm TCA cycle 
mutants” the role of central metabolism in virulence was examine in the O1 serotype 
strain of V. anguillarum NB10Sm. A V. anguillarum NB10Sm icd mutant was created, 
characterized for growth in complex media and demonstrated to be as virulent as the wild 
type in juvenile rainbow trout. Several additional central metabolism single and double 
mutants were created in the following genes cra, gltA, Δicd gltA, sucA, sucC, sdhC, 
ΔfrdA, ΔfrdA sdhC, and fumA and characterized with regard to growth in complex media. 
Two mutants (ΔsucA and ΔfrdA ΔsdhC) that demonstrated a significantly reduced growth 
 yield compared to the wild type were further characterized with regard to their growth in 
several forms of complex media, expression of virulence genes, and virulence in juvenile 
rainbow trout. The data strongly suggest that there is no correlation between a lower 
growth yield in vitro and a decrease in virulence in vivo. Even though M93Sm and 
NB10Sm are same species, mutations made in the same TCA cycle genes can cause 
drastically difference results in regards to growth and virulence. 
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PREFACE 
This dissertation has been prepared in the Manuscript format according to the 
guidelines of the Graduate School of the University of Rhode Island. The first manuscript 
“Isocitrate dehydrogenase mutation in Vibrio anguillarum results in virulence attenuation 
and immunoprotection in rainbow trout (Oncorhynchus mykiss)” was submitted to BMC 
Microbiology July 31st 2017 and is under revision. The second manuscript 
“Characterization of the growth and virulence of a Vibrio anguillarum citrate synthase 
mutant” and the third manuscript “Characterization of Vibrio anguillarum NB10Sm TCA 
cycle mutants” will be submitted for publication to BMC Microbiology. The first 
appendix “Draft genome of the marine pathogen Vibrio coralliilyticus RE22” was 
published Dec 3rd 2015 in Genome Announcements. The second appendix “Draft 
genome sequence of the emerging bivalve pathogen Vibrio tubiashii subsp. europaeus” 
was published July 28th 2016 in Genome Announcements. 
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Abstract 
 
Background: Vibrio anguillarum is an extracellular bacterial pathogen that is a causative 
agent of vibriosis in finfish and crustaceans with mortality rates ranging from 30% to 
100%. Mutations in central metabolism (glycolysis and the TCA cycle) of intracellular 
pathogens often result in attenuated virulence due to depletion of required metabolic 
intermediates; however, it was not known whether mutations in central metabolism 
would affect virulence in an extracellular pathogen such as V. anguillarum.  
Results: Seven central metabolism mutants were created and characterized with regard to 
growth in minimal and complex media, expression of virulence genes, and virulence in 
juvenile rainbow trout (Oncorhynchus mykiss). Only the isocitrate dehydrogenase (icd) 
mutant was attenuated in virulence against rainbow trout challenged by either 
intraperitoneal injection or immersion. Further, the icd mutant was shown to be 
immunoprotective against wild type V. anguillarum infection. There was no significant 
decrease in the expression of the three hemolysin genes was detected by qRT-PCR. 
Additionally, only the icd mutant exhibited a significantly decreased growth yield in 
complex media. Growth yield was directly related to the abundance of glutamate. A 
strain with a restored wild type icd gene was created and shown to restore growth to a 
wild type cell density in complex media and pathogenicity in rainbow trout. 
Conclusions: The data strongly suggest that a decreased growth yield, resulting from the 
inability to synthesize α-ketoglutarate, caused the attenuation despite normal levels of 
expression of virulence genes. Therefore, the ability of an extracellular pathogen to cause 
disease is dependent upon the availability of host-supplied nutrients for growth. 
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Additionally, a live vaccine strain could be created from an icd deletion strain.  
Keywords: Vibrio anguillarum, TCA cycle, vibriosis, isocitrate dehydrogenase, 
virulence, hemolysin 
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Background 
The aquaculture industry now produces half of all fish intended for human 
consumption and employs millions of people worldwide [1]. Although the first value sale 
of harvested fish has increased by 267% between 2004 and 2014 to over US$160 billion, 
infectious diseases, especially those caused by Vibrio spp. including Vibrio anguillarum, 
still represent a major impediment to the production of fish [1]. V. anguillarum causes 
diseases in crustaceans and bivalves, and is the leading causative agent of vibriosis in 
finfish including salmon, rainbow trout, turbot, sea bass, sea bream, cod, eel, and ayu [2]. 
Infections by this bacterial species have resulted in severe economic losses to aquaculture 
industries worldwide [3]. 
V. anguillarum is an extracellular pathogen that invades its host fish through the 
intestine, skin or gills [4, 5]. Systemic infection by V. anguillarum usually causes fish to 
die within 1-4 days [6-9]. Chemotactic motility and the metalloprotease EmpA have been 
shown to be important virulence factors during the invasion stage while the siderophore 
anguibactin, flagellin subunits and lipopolysaccharides were shown to be important for 
persistence in the host during the post-invasion stage [2, 10]. Three secreted proteins that 
are cytotoxic against epithelial cells and erythrocytes have been characterized in V. 
anguillarum: the HlyA homolog Vah1, the phospholipase Plp, and the MARTX toxin 
RtxA [7, 9, 11]. Mutations in vah1 and/or plp resulted in slight attenuation against 
juvenile Atlantic salmon (Salmo salar); however, rtxA mutants were avirulent [11, 7, 9]. 
Additionally, a V. anguillarum mutant that lacks H-NS, a global transcriptional regulator 
that represses the transcription of vah1, plp, and rtxA, showed attenuation in virulence 
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when injected intraperitoneally, suggesting that proper coordination of gene expression is 
an important factor during the post-invasion stage [8]. 
Since the 1980s, several bacterial species that are auxotrophic for aromatic 
compounds have been shown to be avirulent [12-16]. More recently, mutants that are 
hypothesized to experience growth defects in the nutrient limited environment inside a 
phagocyte have been characterized. In Salmonella enterica, an intracellular bacterial 
pathogen, some tricarboxylic acid (TCA) cycle mutant strains were avirulent and 
immunoprotective for subsequent wild-type S. enterica infection [17-21]. A functional 
fructose repressor (Cra) was also required for S. enterica infection [22]. Similar results 
have been observed for central metabolism mutants in other intracellular pathogens such 
as uropathogenic Escherichia coli (UPEC), Mycobacterium tuberculosis, and the 
facultative intracellular fish pathogen Edwardsiella ictaluri [23-27]. These observations 
demonstrate that central metabolism is important for pathogenesis by intracellular 
pathogens. 
Accordingly, we hypothesized that mutations in central metabolism could 
interrupt the infection process of V. anguillarum in juvenile rainbow trout (Oncorhynchus 
mykiss). In this study, we identified and created six TCA cycle mutant strains plus one 
fructose metabolism mutant strain, and tested their virulence against juvenile rainbow 
trout using two infection methods, intraperitoneal (IP) injection and immersion. Further, 
the expression of each of the three hemolysin genes (vah1, plp, and rtxA) was examined 
to determine whether attenuation resulted from decreased virulence factor expression in 
these mutants. The growth rates and yield of each mutant strain in complex media were 
also determined. We specifically characterized the growth defect of the attenuated icd 
6 
 
mutant. We also created, tested, and compared a restored wild type icd strain for 
virulence and growth to both the wild type and the icd mutant. 
Methods 
Bacterial strains, plasmids and growth conditions. V. anguillarum strains (Table 1) 
were routinely grown in Lysogeny broth containing 2% NaCl (LB20) [28] or Marine 
Minimum Median (3M) + 0.15% glucose [29], supplemented with the appropriate 
antibiotic, in a shaking water bath at 27°C. E. coli strains (Table 1) were routinely grown 
in Lysogeny broth containing 1% NaCl (LB10) supplemented with the appropriate 
antibiotic, in a shaking water bath at 37°C. Antibiotics were used at the following 
concentrations: streptomycin, 200 g/ml (Sm200); chloramphenicol, 20 g/ml (Cm20) for 
E. coli and 5 g/ml (Cm5) for V. anguillarum; kanamycin, 50 g/ml (Km50) for E. coli 
and 80 g/ml (Km80) for V. anguillarum.  
Identification of genes in V. anguillarum. V. anguillarum M93Sm draft genome 
(accession number NOWD00000000) was annotated by the RAST (Rapid Annotation 
using Subsystem Technology) service (http://rast.nmpdr.org/rast.cgi) using the default 
settings [30]. The following annotated genomes were downloaded from NCBI: V. 
anguillarum 775 (accession numbers: NC_015633.1 and NC_015637.1), 96F (accession 
number: NZ_AEZA00000000.1), M3 (accession numbers: NC_022223.1, NC_022224.1 
and NC_022225.1), NB10 (accession numbers: NZ_LK021130.1, NZ_LK021129.1 and 
NZ_LK021128.1), RV22 (accession number: AEZB00000000.1) and 90-11-286 
(accession numbers: NZ_CP011460.1 and NZ_CP011461.1) 
Insertional mutagenesis. Insertional mutations were made by using a modification of the 
procedure described by Milton et al. [31]. Briefly, primers (Table 2) were designed based 
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on the target gene sequence of M93Sm. An internal 200-300 bp DNA fragment of the 
first third of the target gene was PCR amplified and ligated into the suicide vector 
pNQ705-1 (Table 1) after digestion with SacI and XbaI. The ligation mixture was 
introduced into E. coli SM10 by electroporation using a BioRad Gene Pulser II (BioRad, 
Hercules, CA). Transformants were selected on LB10 Cm20 agar plates. The construction 
of the recombinant pNQ705 was confirmed by both PCR amplification and restriction 
enzyme analysis. The mobilizable suicide vector was transferred from E. coli SM10 into 
V. anguillarum by conjugation [32]. Transconjugants were selected by utilizing the 
chloramphenicol resistance gene located on the suicide plasmid. The incorporation of the 
recombinant pNQ705 was confirmed by PCR amplification. 
Fish infection experiments. Various V. anguillarum strains were tested for virulence 
against rainbow trout (O. mykiss) by intraperitoneal (IP) injection or immersion. 
Briefly, V. anguillarum cells grown for 19 h at 27°C in LB20 supplemented with the 
appropriate antibiotics were harvested by centrifugation (9,000 × g, 5 min, 4°C), washed 
twice in NSS, and resuspended in NSS. Aliquots (100 µl) of the V. anguillarum NSS 
suspension were used to determine the OD600. The V. anguillarum NSS suspension was 
prepared to the desired specific cell density according to the conversion equation as 
determined by experimentation (data not shown): Cell density (108 CFU/ml) = 44.905 × 
OD600. The actual cell density of the suspension was confirmed by dilution and viable 
plate count. All fish were examined and determined to be disease and injury free prior to 
the start of each experiment. For IP injection, fish were anesthetized by tricaine 
methanesulfonate (Western Chemical, Ferndale, WA), (100 mg/l for induction and 52.5 
mg/l for maintenance). V. anguillarum strains were IP injected into fish that were 
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between 15 and 25 cm long in a 100 μl NSS vehicle at a dose of either 2 × 105 or 4 × 105 
CFU/fish, or with NSS only as a negative control. For immersion, 10 ml of V. 
anguillarum suspended in NSS, or 10 ml of NSS only as a negative control was added to 
a bucket filled with 10 L of water supplemented with 1.5% NaCl that was maintained at 
18 ± 1ºC. Fish that were between 15 and 25 cm long were added and immersed for 1 h. 
For both methods, fish inoculated with different bacterial strains were maintained in 
separate 10-gallon (38 L) tanks to prevent possible cross-contamination with constant 
water flow (200 ml/min) at 18 ± 1ºC. Death due to vibriosis was determined by the 
observation of gross clinical symptoms and confirmed by the recovery and isolation of V. 
anguillarum cells resistant to the appropriate antibiotics from the spleen or head kidney 
of dead fish. Observations were made for 8-14 days. All fish used in this research project 
were obtained from the URI East Farm Aquaculture Center. All fish infection protocols 
were approved by the URI IACUC. (IACUC Protocol AN06-08-002). 
RNA isolation. Exponential phase cells (~0.5 × 108 CFU/ml) of various V. anguillarum 
strains were treated with RNAprotect Bacteria Reagent (QIAGEN), following the 
manufacturer’s instructions. Total RNA was isolated using the RNeasy kit and QIAcube 
(QIAGEN) following the instructions of the manufacturer. All purified RNA samples 
were quantified spectrophotometrically by measuring absorption at 260 nm and 280 nm 
using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific) and overall 
quality was assessed by gel electrophoresis. Samples were stored at -75ºC for future use. 
Real-time quantitative RT-PCR (qRT-PCR). qRT-PCR was used to quantify various 
mRNAs using an LightCycler® 480 Real-Time PCR System (Hoffmann-La Roche Inc.) 
and the Brilliant II SYBR Green Single-Step QRT-PCR Master Mix (Agilent 
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Technologies), with 10 ng of total RNA in 20 µl reaction mixtures. The thermal profile 
was 50°C for 30 min, 95°C for 15 min, and then 40 cycles of 95°C for 30 s and 55°C for 
30 s. Fluorescence was measured at the end of the 55°C stage of each cycle. Samples 
were run in triplicate along with the no-reverse-transcriptase control and the no-template 
control. All experiments were repeated at least twice. 
Growth experiments. To cultivate bacteria for growth experiments, V. anguillarum cells 
grown overnight at 27°C in LB20 supplemented with the appropriate antibiotics were 
harvested by centrifugation (9,000 × g, 2 min), washed twice and resuspended in in NSS. 
A 200 µl aliquot of the V. anguillarum NSS suspension was transferred into a 96-well 
plate with a clear flat bottom and the optical density at 600 nm (OD600) was read by a 
VersaMax™ Absorbance Microplate Reader (Molecular Devices). The V. 
anguillarum NSS suspension was prepared to an OD600 of 0.420 (~4 × 10
7 CFU/ml) and 
diluted 1:100 into fresh media. Growth was monitored either by measurement of the 
OD600 or by serial dilution and plate counts. 
Resolving the merodiploid in the icd mutant. V. anguillarum icd mutant cells grown in 
LB20 supplemented with appropriate antibiotics for 19 h at 27°C were harvested by 
centrifugation (9,000 × g, 2 min), washed three times in NSS, and resuspended in NSS. 
Cell suspensions (100 μl) were spread onto Marine Minimum Median (3M) + 0.15% 
glucose agar. Well-isolated colonies were picked and subsequently streak purified onto a 
new 3M + 0.15% glucose agar. Isolated colonies were then transferred to LB20-Cm5 agar 
to screen for chloramphenicol sensitivity. Resolution of the merodiploid was confirmed 
by PCR amplification. 
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Statistical analysis. A Kaplan-Meier survival analysis with log rank significance test was 
performed on the survival curves in the fish infection experiment. Student's T-tests 
assuming unequal variances were used for experiments containing two data groups. One-
way ANOVA with Tukey post hoc test was performed for all other experiments. P values 
of <0.05 were considered statistically significant. 
Results 
Identification and mutant construction of TCA cycle genes in V. anguillarum. In 
order to identify gene targets for mutagenesis the published genomes of V. anguillarum 
strains 775, 96F, M3, NB10, RV22, 90-11-286 and the V. anguillarum M93Sm draft 
genome (unpublished data) annotated by RAST were examined and found to have the 
following TCA cycle genes/operons: gltA, acnB, icd, sucAB, sucCD, sdhCDAB, frdABCD 
fumA, and mdh (Fig. 1 and Table 3). While this set of genes allows for a fully functional 
TCA cycle, none of the strains have a fumC gene, which encodes the aerobic fumarate 
class II hydratase. All strains also lack the anaerobic fumarate hydratase (fumB) gene. 
Additionally, all strains possessed cra, which encodes the repressor of fructose 
metabolism in S. enterica [22]. The V. anguillarum M93Sm sequences for the icd, sucA, 
sucC, sdhC, fumA, mdh, and cra genes were used to create insertional mutations in V. 
anguillarum M93Sm. The seven mutant strains and the one restored strain listed in Table 
1 were constructed using the primers listed in Table 2 as described in the Methods. 
icd mutant is highly attenuated for virulence against rainbow trout. The virulence of 
the seven V. anguillarum metabolism mutants were tested on rainbow trout and compared 
to wild type M93Sm in order to determine if mutations in metabolism could affect 
pathogenesis. Groups of five fish were infected by IP-injection (as described in the 
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Methods) with either the wild type (M93Sm), icd mutant (XM420), sucA mutant 
(XM440), sucC mutant (XM450), sdhC mutant (XM460), fumA mutant (XM470), mdh 
mutant (XM410) or cra mutant (XM430) in NSS at a dosage of ~2×105 CFU per fish. 
Injection with NSS only served as a negative control (Mock). During the 14-day 
observation window, 40% of M93Sm infected fish survived. Fish infected with the sucA 
mutant, sdhC mutant or icd mutant had a higher survival percentage than M93Sm (50% 
for sucA mutant, 80% for sdhC mutant, and 100% for icd mutant); however, only the 
difference between the icd mutant and M93Sm was statistically significant (p = 0.037) 
(Fig 2A). The experiment was repeated using a two-fold higher dose (~4×105 CFU per 
fish) of M93Sm and the three mutant strains (icd mutant, sucA mutant and sdhC mutant) 
that exhibited attenuated virulence in the previous experiment. At this dose, only 20% of 
M93Sm-infected fish survived. Only the icd mutant-infected fish had a statistically 
significant higher survival percentage (100%) compared to M93Sm (p = 0.0153) (Fig 
2B). The data indicate the icd mutant is avirulent in these experimental conditions.  
Further, we tested the virulence of M93Sm and the icd mutant by another 
infection route. Groups of 10 fish were infected by immersion as described in the 
Methods with M93Sm or icd mutant in 1.5% salt solution at a dose of ~4×106 CFU/ml, or 
just immersed in a 1.5% salt solution without V. anguillarum as a negative control 
(Mock). During the 14-day observation window, there was a statistically significant 
difference (p = 0.007) between the survival of M93Sm infected fish (30%) and icd 
mutant infected fish (90%) (Fig. 3). Taken together, the IP infection data and the 
immersion infection data demonstrate that the icd mutant is highly attenuated for 
infection in rainbow trout. 
12 
 
Pre-treatment by immersion with the icd mutant protected rainbow trout from the 
subsequent challenge of V. anguillarum M93Sm. Fish previously challenged by 
immersion with the icd mutant were subsequently challenged with the wild type M93Sm 
strain to test if the icd mutant was immunogenic. Six weeks after the initial infection, a 
group of five fish that survived the initial infection with the icd mutant (labeled as 
“treated with the icd mutant” in Fig. 4) and a group of five “untreated” fish were infected 
via immersion with M93Sm at a dose of ~4×106 CFU/ml and were observed for 14 days. 
By day 2 all fish in the untreated group died. All fish in the group treated with the icd 
mutant survived the 14-day observation period. The difference between the two 
experimental groups was statistically significant (p = 0.008). The results indicate that the 
icd mutant is immunogenic and protective against wild type infection when administered 
by immersion. 
All mutants exhibited either same or higher expression levels of the three hemolysin 
genes compared to wild type. Vah1, RtxA, and Plp are the three hemolysins found in 
M93Sm and are responsible for the hemolytic/cytolytic activity against fish erythrocytes, 
leukocyte and epithelial cells [11, 7, 9] and unpublished data]. We tested the expression 
of vah1, rtxA and plp during exponential phase to determine whether mutations in 
metabolism could affect the expression of these hemolysin genes. Data indicate that in all 
mutants except the icd mutant, expression of vah1 and plp were up regulated by 1.49-
16.15-fold compared to M93Sm with most of the changes being significant (Fig. 5). In 
the icd mutant, expression of plp was up regulated by 1.76-fold while the expression of 
vah1 was slightly decreased (to 49% of WT), neither of which was a significant change 
from M93Sm (Fig. 5). Plp is the most efficient hemolysin against fish erythrocytes [11]. 
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TCA cycle mutants with an increased expression of plp also demonstrated an increased 
zone of hemolysis on 5% fish blood agar plates (Fig. S2). There was no change in the 
zone of hemolysis for the icd mutant. Expression of rtxA in all mutants was not 
significantly different from M93Sm (Fig. 5). Taken together, all metabolism mutants 
have the same or higher expression levels of hemolysin genes compared to the wild type. 
icd mutant exhibited significant lower cell density limit than wild type in two forms 
of rich media. Fig. 6 shows the typical growth curves for the wild type V. anguillarum 
M93Sm and the seven metabolism mutants in LB20 broth. In these growth conditions, 
M93Sm, the icd mutant, and the cra mutant exhibited classic bacterial growth curves 
with a lag phase, an exponential phase and a stationary phase. The sucA, sucC, sdhC, 
fumA and mdh mutants all exhibited a two-stage growth curve, with each stage consisting 
of a lag phase and an exponential phase. The exponential phase in the first growth stage 
was named exponential phase I and the exponential phase in the second growth stage was 
named exponential phase II. The generation times of the exponential phases of all 
mutants were longer than for M93Sm (Table 4). The final cell density (measured by 
OD600) of the icd mutant after 23 h was the lowest among all strains. Similarly, after 24 h 
of growth in LB20 the final cell density (CFU/ml) of the icd mutant was 47% that of 
M93Sm (Table 5) and the difference is significant (p = 0.011). M93Sm and the icd 
mutant were grown in NSS supplemented with 200 µg protein/ml of fish gastrointestinal 
mucus (NSSM) to better replicate conditions within a host. After 24 h of growth in 
NSSM the final cell density of the icd mutant was only ~31% of that for M93Sm (Table 
5) and the difference is significant (p = 0.007).  
Growth in LB20 supplemented with 118 mM glutamate restores growth of the icd 
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mutant to wild type levels. The icd mutant is unable convert isocitrate into α-
ketoglutarate, the immediate precursor of glutamate. Consequently, the icd mutant was 
only able to grow in 3M + 0.15% glucose with the addition of glutamate (Fig. 7A). 
Glutamate was added to LB20 to determine if the icd mutant final cell density would 
increase. Fig. 7B shows the typical growth curves of M93Sm and the icd mutant in LB20 
with (solid lines) and without (dashed lines) the addition of 118 mM of glutamate. After 
24 h, M93Sm and the icd mutant grew to similar final cell densities when LB20 was 
supplemented with 118 mM glutamate. Additionally, Fig. 7C demonstrate that decreasing 
the amount of glutamate (from 118 mM to 2.95 mM) added to LB20 decreases the final 
cell density of the icd mutant, but not M93Sm, after 24 h of growth. The final cell density 
of the icd mutant was not restored to a wild type level when LB20 was supplemented 
with glucose, succinate (Fig. S3) or gluconate (Fig. 7C).  
Resolving the merodiploid in the icd mutant restores growth and pathogenicity. A 
revertant to the wild type icd gene was selected to demonstrate that the icd mutant 
(XM420, a merodiploid with an insertion in the icd gene) contained no additional 
mutations that could be causing the loss of pathogenicity and decreased cell density. 
Initially, attempts were made to complement the icd mutant in trans by cloning icd and 
its native promoter into the pSUP203 vector; however, all pSUP203-icd vectors isolated 
from E. coli SM10 contained single nucleotide substitutions that resulted in amino acid 
changes in icd that inactivated isocitrate dehydrogenase (data not shown). Since the icd 
mutant is unable to grow on 3M + glucose, icd mutants that spontaneously resolved the 
merodiploid were isolated on 3M + glucose agar plates as described in the Methods. The 
reversion rate of the icd mutant to a wild type phenotype grown in LB20 overnight was 
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calculated to be 1 out of 1.6 × 1010 cells. Fig. S1 shows the typical growth curves for 
M93Sm, the icd mutant and the restored icd strain in LB20 and 3M + 0.15% glucose. 
M93Sm and the restored icd strain were able to grow in 3M + 0.15% glucose unlike the 
icd mutant (Fig S1A). Additionally, when the strains were grown in LB20 the final cell 
density returned to wild type levels when icd was restored (Fig. S1B). To determine if 
restoring icd restores pathogenicity, juvenile rainbow trout were challenged via 
immersion with M93Sm, the icd mutant and the restored icd strain at a dose of between 
4×106 and 8×106 CFU/ml. After day 8, 26% (5/19) of the M93Sm challenged fish, 40% 
(6/15) of the restored icd challenged fish and 95% (19/20) of the icd mutant challenged 
fish survived (Fig. 8). There was no statistically significant difference between M93Sm 
and the restored icd strain (P = 0.50). Again, there was a statistically significant 
difference between M93Sm and the icd mutant (p < 0.00004). The results indicate that 
when the merodiploid present in the icd mutant is resolved, wild type levels of growth in 
3M + 0.15% glucose and LB20 and pathogenicity against juvenile rainbow trout is 
returned.  
Discussion 
The tricarboxylic acid (TCA) cycle is involved in the generation of energy 
through the oxidation of acetate. TCA intermediates serve as precursor metabolites for 
the synthesis of amino acids and peptidoglycan. The M93Sm genome along with the 
published genomes of V. anguillarum strains 775, 96F, M3, NB10, RV22, 90-11-286 
were examined for TCA cycle enzymes and the following genes were found: gltA, acnB, 
icd, sucAB, sucCD, sdhCDAB, frdABCD fumA, and mdh (Fig. 1 and Table 3). 
Additionally, cra, which encodes the repressor of fructose metabolism in S. enterica and 
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E. coli and has previously been shown to be essential for S. enterica virulence, is present 
in the V. anguillarum genomes [22].  
When in a nutrient limited environment, bacteria must be able to synthesize any essential 
metabolites that are not freely available in order to grow. Previous studies have shown 
that mutations in central metabolism genes result in attenuation of virulence in several 
intracellular pathogens including S. enterica, uropathogenic E. coli (UPEC), M. 
tuberculosis and E. ictaluri [19, 21, 26, 23-25, 17, 18]. These observations suggest that 
central metabolism is necessary for these intracellular pathogens to function inside the 
nutrient-limited environment of the phagosome; however, V. anguillarum is not an 
intracellular pathogen. While some studies have suggested that V. anguillarum can 
survive internally in fish epithelial cells and CHSE cells (derived from pooled embryonic 
cells from Oncorhynchus tshawytscha), more recent studies have demonstrated that V. 
anguillarum actively evades phagocytosis by fish epithelial cells and cannot survive for 
24 h in macrophages [33-36]. In this study, fish were infected with V. anguillarum strains 
by either of two methods: intraperitoneal injection or immersion with both methods 
resulting in a similar percent survival when fish were challenged with M93Sm (20% for 
injection, see Fig 2A and 2B; 0%~30% for immersion, see Fig. 3). Only the icd mutant 
had a statistically significant higher level of survival compared to the wild type, 100% for 
IP injection (Fig 2A and 2B) and 90% for immersion (Fig. 3). It is not thought that 
reversion of the merodiploid to a wild type phenotype caused the other metabolism 
mutants to be virulent because Cm resistant colonies were isolated from the organs of 
dead fish. IP injection bypasses the need for invasion. No mortalities resulted from IP 
injection with the icd mutant indicating that icd is required for V. anguillarum persistence 
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and growth in fish tissues. Rainbow trout infected with the icd mutant via immersion and 
subsequently challenged with the M93Sm wild type showed 100% survival (Fig. 4) 
demonstrating that the icd mutant had immunoprotective effects and elicited an adaptive 
immune response. Moreover, as a proof of concept, the data suggest that an icd deletion 
mutant could be the basis for a live attenuated vaccine against V. anguillarum infection.  
Our observation that a knockout of the icd gene results in attenuation of virulence 
raises the question of whether expression of required virulence genes is significantly 
reduced in the mutant and, therefore, results in attenuation. We previously identified and 
characterized three hemolysin/cytolysin genes and their encoded proteins secreted by V. 
anguillarum: plp, vah1 and rtxA [11, 7, 9]. While mutations in plp and vah1 have modest 
effects on virulence against fish epithelial cells and fish, a knockout mutation in rtxA is 
avirulent in fish [11, 7, 9]. All metabolism mutants exhibited no significant declines in 
the expression of three hemolysins (Fig. 5) and most of the mutants exhibited increased 
expression. Accordingly, the icd mutant is not attenuated by the lack of hemolysin 
production because the decrease in rtxA and vah1 expression was not significant; 
however, future studies could examine the expression of other virulence factors. It is 
unclear why expression of plp and vah1 is increased in the metabolism mutants. Minato 
et al [37] demonstrated the accumulation of acetyl-CoA in Vibrio cholerae central 
metabolism mutants resulted in an increased expression of its virulence gene activator 
ToxT. It is possible that accumulation or depletion of certain metabolites in V. 
anguillarum could increase hemolysin/cytolysin expression. Expression of hlyU, the 
positive regulator of the both the vah1 plp gene cluster and the rtxA gene cluster, was 
examined and shown to be up-regulated in the sucA and mdh mutants (data not shown) 
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[38]. However, the increased expression of hlyU may not be the sole explanation for the 
increased expression of plp and vah1 because an increase in expression of rtxA should 
have also occurred.  
The growth rate and final cell density was determined for all metabolism mutants grown 
in LB20 for 24 h. The slowest growing mutant, fumA, was as virulent as the wild type 
while the mutant with the lowest final cell density, icd, was attenuated suggesting that 
decreased final cell density results in a loss of pathogenicity against rainbow trout (Fig. 2, 
Fig. 6, Table 4 and Table 5). When the mutation in icd was resolved, the restored icd 
strain demonstrated the wild type phenotype for both growth and pathogenicity (Fig. S1A 
and B and Fig. 8). While it is possible that the insertional mutation affected the 
expression of the two genes flanking icd (ribosomal large subunit pseudouridine synthase 
E (Accession number: WP_017043910.1) and cold shock domain protein CspD 
(Accession number: WP_013857087.1)), it is unlikely as neither gene is part of an operon 
that includes icd. Since isocitrate dehydrogenase catalyzes the formation of α-
ketoglutarate (the immediate precursor of glutamate) from isocitrate, the icd mutant is 
auxotrophic for glutamate (Fig. 7A). Our data demonstrate that the icd mutant stops 
growing once exogenous glutamate or its derivatives are exhausted (Fig. 7B and Fig. 7C). 
The data also demonstrate the decreased growth yield was not do to a reduction of ATP 
production as addition of gluconate or succinate did not restore growth to a wild type cell 
density. It is interesting that the only other auxotrophic mutant, sucA, grows to a wild 
type cell density in LB20 and is as virulent as the wild type considering it cannot 
synthesize succinyl-CoA, a metabolite needed for the synthesis of lysine, methionine and 
diaminopimelic acid. Presumably, succinyl-CoA or its derivatives are not limiting in 
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LB20 or in fish tissues. Furthermore, this also suggests that the icd mutant is primarily 
starved for glutamate and would not need to synthesize succinyl-CoA by metabolizing 
glutamate to α-ketoglutarate. We hypothesize that during infection the icd mutant is 
unable to obtain enough α-ketoglutarate derivatives to grow to a wild type cell density 
and, therefore, cannot reach a cell density necessary for a successful systemic infection. 
In support, it has previously been demonstrated that a V. anguillarum M93Sm mugA 
mutant that was unable to grow in salmon intestinal mucus was avirulent against Atlantic 
salmon [39]. Additionally, when V. anguillarum 775 was cured of its plasmid-encoded 
siderophore, the mutant was unable to sequester iron and exhibited decreased virulence. 
[40, 41].  
M93Sm is an O2α serotype and the presumed infection route is through the 
gastrointestinal tract as no necrotic skin lesions have ever been observed with this strain 
(unpublished data). The in vitro growth experiment (Table 5) suggests that there are not 
enough α-ketoglutarate derivatives in intestinal mucus to support the growth of the icd 
mutant to a wild type cell density even though it is the metabolite with the second highest 
concentration (3.03 mM) in rainbow trout mucus [42]. It should be noted that for in vitro 
growth experiments the concentrations of glutamate and glutamine in the mucus are not 
known and the growth conditions represent an ideal environment for growth; V. 
anguillarum does not have to evade the fish immune system or compete with commensal 
bacteria and it is not expected that the icd mutant will grow to the cell density shown in 
the in vitro growth experiments in the fish. As demonstrated by Muroga et al, [43] V. 
anguillarum found in the spleen and intestine of moribund fish challenged via immersion 
only reached a cell density of 4.0×108 CFU/g and 2.5×107 CFU/g respectively. Altinok et 
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al [44] showed a V. anguillarum succinate dehydrogenase mutant was avirulent against 
rainbow trout when injected at a dose at 105 CFU. Similar to our results, the authors 
showed that the succinate dehydrogenase mutant grew to a cell density slightly lower 
than the wild type at 12 h; however, the authors failed to show the growth yield at 24 h. 
Further, the authors did not create a complement strain to demonstrate that the loss of 
virulence was solely do to mutating sdhB. Most importantly, the ATCC has redesignated 
their strain as a Pseudomonas species. 
Conclusions 
Seven V. anguillarum metabolism mutants were created and examined for 
pathogenicity against juvenile rainbow trout, hemolysin/cytolysin expression and growth 
in rich media. Of the central metabolism mutants, only the icd mutant showed strong 
attenuation in virulence, which did not result from a decrease in virulence factor 
expression. In addition, only the icd mutant had a final cell density that was lower than 
the wild type, which resulted from the inability to synthesize α-ketoglutarate and 
downstream metabolites. Taken together, the data suggest that during infection, if V. 
anguillarum is unable to synthesize essential molecules (e.g. α-ketoglutarate/2-
oxoglutarate) and when those molecules or their derivatives (e.g. glutamate, glutamine) 
become limiting in the host, V. anguillarum will be unable to grow to a density necessary 
to sustain a systemic infection of the host.  
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Table 1. Bacterial strains and plasmids used in this study 
Strain or plasmid Description Reference 
V. anguillarum 
strains 
    
M93Sm Spontaneous Sm
r
 mutant of M93 (serotype O2a) [45] 
XM420 Sm
r
 Cm
r
; icd insertional mutant This study 
ES422 Sm
r
; Restored icd strain  This study 
XM440 Sm
r
 Cm
r;
 sucA insertional mutant This study 
XM450 Sm
r
 Cm
r;
 sucC insertional mutant This study 
XM460 Sm
r
 Cm
r;
 sdhC insertional mutant This study 
XM470 Sm
r
 Cm
r;
 fumA insertional mutant This study 
XM410 Sm
r
 Cm
r;
 mdh insertional mutant This study 
XM430 Sm
r
 Cm
r;
 cra insertional mutant This study 
E. coli strains   
Sm10 
thi thr leu tonA lacY supE recA RP4-2-Tc::Mu::Km 
(λ pir) 
[46] 
S100 Km
r
; Sm10 containing plasmid pNQ705-1 [47] 
Q420 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-icd This study 
Q440 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-sucA This study 
Q450 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-sucC This study 
Q460 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-sdhC This study 
Q470 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-fumA This study 
Q410 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-mdh This study 
Q430 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-cra This study 
Plasmid   
pNQ705-1 Cm
r
; suicide vector with R6K origin [47] 
pNQ705-icd  Cm
r
; For icd insertional mutant This study 
pNQ705-sucA Cm
r
; For sucA insertional mutant This study 
pNQ705-sucC Cm
r
; For sucC insertional mutant This study 
pNQ705-sdhC Cm
r
; For sdhC insertional mutant This study 
pNQ705-fumA Cm
r
; For fumA insertional mutant This study 
pNQ705-mdh Cm
r
; For mdh insertional mutant This study 
pNQ705-cra Cm
r
; For cra insertional mutant This study 
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Table 2. Primers used in this study. 
Primer 
Sequence (5' to 3', 
underlined sequences are 
designed restriction sites) 
Description 
Referenc
e 
pr31 
GGTGAGCTCTATTCTTTATT
GCCGATTATC 
For icd insertional mutant, 
forward, SacI 
This study 
pr32 
AAATCTAGAGTAAGTCGCTT
TAATCGCTTC 
For icd insertional mutant, 
reverse, XbaI 
This study 
pr50 
AAAGAGCTCGTGATCCAGA
TGTCGATGCTA 
For sucA insertional mutant, 
forward, SacI 
This study 
pr51 
GGTTCTAGAGTTCAGTGTC
GATAATGTGCA 
For sucA insertional mutant, 
reverse, XbaI 
This study 
pr52 
AAAGAGCTCGGTCGGATTA
GTACAGCGAAG 
For sucC insertional mutant, 
forward, SacI 
This study 
pr53 
GGTTCTAGACTTTTTCAATT
TCCACGCCGC 
For sucC insertional mutant, 
reverse, XbaI 
This study 
pr54 
AAAGAGCTCATGTTCGTTGC
GGTCGGAATT 
For sdhC insertional mutant, 
forward, SacI 
This study 
pr55 
GGTTCTAGATCCAACTCTTC
AAAGTGGCCC 
For sdhC insertional mutant, 
reverse, XbaI 
This study 
pr56 
GGTGAGCTCTCCTTGCACC
ATATTGATATG 
For fumA insertional mutant, 
forward, SacI  
This study 
pr57 
GGGTCTAGAAGGCTTATCA
TCGAGAAGAGAG 
For fumA insertional mutant, 
reverse, XbaI 
This study 
pr29 
GGTGAGCTCATGCCAGCGT
TAACATTAAAC 
For mdh insertional mutant, 
forward, SacI 
This study 
pr30 
AAATCTAGAGCTGTATGACA
TCGCACCGGT 
For mdh insertional mutant, 
reverse, XbaI 
This study 
pr33 
AAAGAGCTCGCGGCGTGAG
ACTAAGGCATC 
For cra insertional mutant, 
forward, SacI 
This study 
pr34 
AAATCTAGACAATGGCAAAG
CGCAGAAGTA 
For cra insertional mutant, 
reverse, XbaI 
This study 
vah1 F 
RT  
GTTTGGTATGGAACACCGC
TCAAG 
For vah1 qRT-PCR, forward This study 
vah1 R 
RT 
GGCTCAACCTCTCCTTGTAA
CCAA 
For vah1 qRT-PCR, reverse This study 
plp F RT 
CAGACGACCACCAGTAACC
ACTAA 
For plp qRT-PCR, forward [8] 
plp R RT 
GCAATCATGATGACCCAGC
AACAG 
For plp qRT-PCR, reverse [8] 
Pm111 
GGAAATTATTCCGCCGACG
ATGGA 
For rtxA qRT-PCR, forward [7] 
Pm112 
GCCGATACCGTATCGTTAC
CTGAA 
For rtxA qRT-PCR, reverse [7] 
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Table 3. Metabolism genes examined in this study 
Gene or 
operon 
Product 
Present in sequenced V. 
anguillarum strains a 
gltA Type II citrate synthase Yes 
acnB Aconitate hydratase B Yes 
icd Isocitrate dehydrogenase Yes 
sucAB 
2-oxoglutarate dehydrogenase 
(E1 component, E2 component) 
Yes 
sucCD 
Succinyl-CoA synthetase 
(beta subunit, alpha subunit) 
Yes 
sdhCDAB 
Succinate dehydrogenase 
(cytochrome b556 subunit, membrane 
anchor subunit, flavoprotein subunit, iron-
sulfur protein) 
Yes 
frdABCD 
Fumarate reductase  
(flavoprotein subunit, iron-sulfur subunit, 
anchor subunit, anchor subunit) 
Yes 
fumAC Aerobic fumarate hydratase (class I, class II) 
fumA: Yes; 
fumC: not found 
fumB Anaerobic fumarate hydratase (class I) Not found 
mdh Malate dehydrogenase Yes 
cra Fructose repressor protein Yes 
a V. anguillarum strains: M93Sm 775, 96F, M3, NB10, RV22, 90-11-286 
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Table 4. Generation times of various V. anguillarum strains grown in LB201 
Strain 
Exponential Phase I 
(Minutes) 
Exponential Phase II 
(Minutes) 
M93Sm 44.00  NA 
icd 54.95  NA 
sucA 64.32  98.52  
sucC 52.42  99.57  
sdhC 61.19  101.70  
fumA 73.55  89.38  
mdh 67.11  115.28  
cra 58.59  NA 
1Values calculated from data presented in Figure 6 during exponential growth. 
NA: not applicable 
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Table 5. Final cell density (CFU/ml) of various V. anguillarum cultures grown for 24 h 
Strain CFU/ml in LB20 CFU/ml in NSSM (200 µg/ml) 
M93Sm 3.4×10
9 
(±0.3×10
9
) 4.2×10
9 
(±0.7×10
9
) 
icd 1.6×10
9 
(±0.02×10
9
)* 1.3×10
9
(±0.3×10
9
)* 
*Statistically significant difference compared to M93Sm (p <0.05). 
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Figure Legends 
Figure 1. Embden-Meyerhoff-Parnas Pathway, TCA cycle, and metabolism of fructose. 
The arrows indicate the physiological directions of the reactions. The gene symbols of the 
enzyme for each reaction are listed beside the reaction. Boxed genes indicate the genes 
that were mutated in this study (Table 1).  
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Figure 2. Percent survival of rainbow trout IP injected with V. anguillarum wild type 
(M93Sm) and various mutant strains at a dosage of A) 2×10
5
 CFU/fish and B) 4×10
5
 
CFU/fish. Negative control groups of fish (Mock) were injected with sterile NSS. Five 
fish were used for each treatment. (One fish treated with the sucA mutant died, but not 
from vibriosis and no V. anguillarum were recovered, so only four fish were counted). 
*Statistically significant difference compared to M93Sm (p <0.05).  
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Figure 3. Percent survival of rainbow trout infected by immersion with V. anguillarum 
strains M93Sm (wild type) or XM420 (icd) at a dose of 4×10
6
 CFU/ml. A negative 
control group of fish (Mock) were immersed in sterile NSS. Ten fish were used for each 
treatment. *Statistically significant difference compared to M93Sm (p <0.05). 
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Figure 4. Percent survival of immersion vaccinated rainbow trout. Rainbow trout were 
sham vaccinated with NSS (labeled as “untreated”) or immersed vaccinated with the icd 
mutant (Labeled as “treated with icd”) and challenged with wild type V. anguillarum 
M93Sm (4×10
6
 CFU/ml). Five fish were used for each treatment. *Statistically 
significant difference compared to M93Sm (p <0.05). 
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Figure 5. Relative expression of vah1, plp, rtxA determined by qRT-PCR analysis of V. 
anguillarum wild-type (M93Sm) and various TCA mutants during logarithmic (Log)-
phase growth. The data presented are representative of two independent experiments. 
Each value is the average for three replicates. Between marked strains and M93Sm: * p < 
0.05 and *** p < 0.001. Error bars represent 1 standard deviation.  
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Figure 6. Growth curves of various V. anguillarum strains grown in LB20 at 27°C with 
shaking (200 rpm). At various time points after inoculation samples were taken for 
determination of optical density at 600 nm (OD600). The data are from one representative 
experiment. 
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Figure 7. Growth of V. anguillarum WT (M93Sm) and the icd mutant under various 
conditions. A) Final cell densities (OD600) of V. anguillarum strains after 24 h of growth 
in 3M plus 0.15% glucose supplemented with or without 5.9 mM glutamate. B) Growth 
curves of V. anguillarum M93Sm (black) and the icd mutant (blue) in LB20 (dashed 
lines) or LB20 supplemented with 118 mM glutamate (solid lines). Statistical analysis 
was based on data at 24 h. C) Final cell densities (OD600) of V. anguillarum M93Sm and 
icd mutant strains grown in LB20 supplemented with decreasing amounts of glutamate. 
In each experiment cells grown overnight in LB20 were washed in NSS and used to 
inoculate the appropriate media. Cultures were incubated at 27
o
C in a shaking water bath 
(200 rpm) and at various time points after inoculation samples were taken for 
determination of optical density at 600 nm (OD600). Different letters indicate statistical 
significance among groups (p < 0.05). Error bars represent 1 standard deviation. 
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Figure 8. Percent survival of rainbow trout immersed with various V. anguillarum strains 
at a dosage of 4×10
6
 to 7×10
6
 CFU/ml. Five fish were used for the uninfected (mock) 
group. Fifteen fish were treated with the restored icd strain. Nineteen fish were treated 
with M93Sm and twenty fish were treated with the icd mutant. *Statistically significant 
difference compared to M93Sm (p < 0.01). 
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Supplemental Figure 1. Growth curves of V. anguillarum strains M93Sm (WT), the icd 
mutant and the restored icd strain grown in A) 3M + 0.15% glucose and B) LB20. In each 
experiment cells grown overnight in LB20 at 27°C were washed in NSS and used to 
inoculate the appropriate media. Cultures were incubated at 27
o
C in a shaking water bath 
(200 rpm) and at various times after inoculation, samples were taken for determination of 
optical density at 600 nm (OD600). Different letters indicate statistical significance among 
groups (p < 0.05). Statistical analysis was based on data of stationary phase (>12 h). 
  
43 
 
 
 
 
 
  
0
0.5
1
1.5
0 5 10 15 20 25
O
D
6
0
0
Time (h)
A M93Sm Restored icd icd
0
0.5
1
1.5
0 5 10 15 20 25
O
D
6
0
0
Time (h)
B
M93Sm Restored icd icd             a                                                  a                       b 
             a                                                  a                       b 
44 
 
Supplemental Figure 2. Hemolytic activity of various V. anguillarum strains grown on 
fish blood agar. Colonies grown overnight on LB20 plates were tooth picked onto LB20 
+ 5% trout blood agar plates. The diameter of the zones of hemolysis were measured after 
7 h and 23 h of growth at 27°C. Between marked strains and M93Sm: * p < 0.05 and ** p 
< 0.01. Error bars represent 1 standard deviation.  
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Supplemental Figure 3. Final cell densities (OD600) of V. anguillarum WT (M93Sm) and 
the icd mutant after 24 h of growth in LB20 supplemented with or without 118 mM 
glucose and 118 mM succinate. Error bars represent 1 standard deviation. 
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Abstract 
Background: Vibrio anguillarum is an extracellular bacterial pathogen that is a causative 
agent of vibriosis in finfish and crustaceans with mortality rates ranging from 30% to 
100%. Previously, a V. anguillarum M93Sm isocitrate dehydrogenase mutant 
auxotrophic for glutamate was demonstrated to be attenuated in virulence against juvenile 
rainbow trout. The inability of the mutant to synthesize essential metabolites (i.e. α-
ketoglutarate and derivatives) was hypothesized to cause the attenuation. In this study, a 
citrate synthase mutant was created and characterized to determine if another mutant that 
is auxotrophic for glutamate would be attenuated. 
Results: A citrate synthase (gltA) deletion mutant was created and characterized with 
regard to growth in minimal and complex media, in vitro expression of virulence genes, 
and virulence in juvenile rainbow trout (Oncorhynchus mykiss). The ΔgltA mutant 
exhibited a decreased final cell density that resulted from the exhaustion of glutamate 
from the media. There was no significant decrease in the expression of the three 
hemolysin genes when detected by qRT-PCR or mortality during infection experiments. 
A ΔgltA mutant capable of growing in minimal media was isolated and shown to have a 
spontaneous mutation in the transcriptional activator of 2-methylcitrate synthase (prpR). 
This mutation resulted in an increase in expression of 2-methylcitrate synthase (prpC). 
This ΔgltA prpR(R66L) mutant exhibited a growth advantage compared to the ΔgltA 
mutant after 24 h in spleen extract medium. Further, after growing 120 h in spleen extract 
medium, colonies of ΔgltA mutants were shown to be capable of growing in minimal 
media. ΔprpC and a ΔgltA ΔprpC mutants were created and characterized with regard to 
growth in minimal and complex media and virulence in juvenile rainbow trout. The ΔgltA 
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ΔprpC mutant had no growth advantage in spleen extract medium compared to the ΔgltA 
mutant in spleen extract medium but unexpectedly, was still as virulent as the wild type 
against rainbow trout. The ΔprpC mutant was similar to the wild type in regards to both 
growth in minimal and complex media and virulence against rainbow trout. 
Conclusions: The data strongly suggests that simple starvation for glutamate will not 
directly result in attenuation of virulence. Additionally, spontaneous mutations can occur 
that compensate for the original gene deletion if the new mutation can replace or bypass 
the lost metabolic reaction and results in a growth advantage.  
Keywords: Vibrio anguillarum, Central metabolism, TCA cycle, vibriosis, citrate 
synthase, virulence 
Background 
Vibrio anguillarum is a causative agent of warm water vibriosis in finfish, 
crustaceans and bivalves. Morality rates from infection reach between 30% to 100% and 
result in severe economic losses to aquaculture industries worldwide [1, 2]. Typically, 
systemic infection causes fish to die within 1 to 4 days [3-6]. 
V. anguillarum is an extracellular pathogen capable of invading its host through 
the gills, skin and intestines [7, 8]. Numerous virulence factors that have been shown to 
be important during infection include extracellular proteases, hemolytic cytotoxins, iron 
acquisition systems (siderophores), lipopolysaccharides, chemotaxis, and flagella [9]. 
Three secreted hemolytic cytotoxins, exhibiting activity against multiple cell types have 
been characterized in V. anguillarum: Vah1 (HlyA homolog, encoded by vah1), 
phospholipase Plp (a phosphatidylcholine-specific phospholipase, encoded by plp), and 
the MARTX toxin RtxA (encoded by rtxA) [4, 6, 10]. Expression of the cytotoxins is 
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under control of the transcriptional activator HlyU and the repressor H-NS [5, 11]. 
Mutations in vah1 and/or plp resulted in a slight attenuation in virulence against juvenile 
Atlantic salmon (Salmo salar); however, rtxA mutants cannot persist in host tissues and 
are avirulent against juvenile Atlantic salmon challenged via intraperitoneal injection [4, 
6, 10]. 
Several bacterial species that are auxotrophic for aromatic compounds have been 
shown to be avirulent [12-16]. More recently, central metabolism mutants have been 
shown to be attenuated in pathogenicity in the intracellular pathogens Salmonella 
enterica, uropathogenic Escherichia coli (UPEC), Mycobacterium tuberculosis, and 
Edwardsiella ictaluri, [17-27]. The specific gene mutations that cause attenuation in 
virulence are hypothesized to reflect the metabolic reactions necessary to grow in the 
nutrient limited environment of the phagosome; if the pathogens cannot utilize the 
available nutrients they will fail to multiply to the threshold needed to cause disease [18, 
26]. Recently, a V. anguillarum M93Sm icd mutant was shown to be highly attenuated 
and immunoprotective in juvenile rainbow trout (Oncorhynchus mykiss) [28]. In vitro 
growth experiments demonstrated that the icd mutant grew to a lower cell density (~60%) 
than the wild type in two forms of rich media, due to limiting amounts of α-ketoglutarate 
derivatives (glutamate and glutamine) in the media. In this study, another TCA cycle 
mutant auxotrophic for glutamate was constructed by deleting the citrate synthase gene 
(gltA). The ΔgltA mutant was characterized for growth, hemolysin expression, and 
pathogenicity against juvenile rainbow trout. Additionally, a ΔgltA mutant strain 
containing a spontaneous mutation in the transcriptional regulator prpR capable of 
growing in 3M + 0.15% glucose (a medium which should be unable to support the 
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growth of ΔgltA mutant) was isolated and characterized for growth in multiple forms of 
rich media composed of fish extracts that represent different stages of the infection 
process. Consequently, a ΔprpC (2-methylcitrate synthase) and a ΔgltA ΔprpC mutant 
were created and characterized for growth in multiple forms of media and pathogenicity 
against juvenile rainbow trout. 
Methods 
Bacterial strains, plasmids, and growth conditions. V. anguillarum strains (Table 1) 
were routinely grown in Lysogeny broth containing 2% NaCl (LB20) [29], LB20 + 118 
mM glutamate, Marine Minimum Median (3M) + 0.15% glucose [30], NSSM (NSS 
supplemented with 200µg/ml of fish intestinal mucus) or Spleen extract medium 
supplemented with the appropriate antibiotic, in a shaking water bath at 27°C. Spleens, 
extracted from previously euthanized rainbow or brook trout, were added to 1 ml of NSS, 
placed in an ice-bath and sonicated using Fisher Scientific Sonic Dismembrator Model 
500 four times at 10% power for a continuous 10 s. Tubes were then centrifuged (6000 × 
g, 10 min) and the supernatant was collected and centrifuged again (9000 × g, 10 min). 1 
ml aliquots of the supernatant were added to a sterile 6-well plate (CytoOne) and 
sterilized with ultraviolet light using a Hoefer UV500 (Time = 10 min). An aliquot of the 
supernatant was added to LB20 and observed for growth to ensure that the spleen extract 
was sterile. E. coli strains (Table 1) were routinely grown in Lysogeny broth containing 
1% NaCl (LB10) supplemented with the appropriate antibiotic, in a shaking water bath at 
37°C. Antibiotics were used at the following concentrations: streptomycin, 200 g/ml 
(Sm200); chloramphenicol, 20 g/ml (Cm20) for E. coli and 5 g/ml (Cm5) for V. 
anguillarum. 
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Allelic exchange mutagenesis. Deletion mutations were made by using a modification of 
the procedure described by Milton et al. [31]. Genes of interested were identified using 
the M93Sm genome (Accession Number: NOWD00000000) previously annotated by 
RAST [33]. Briefly, primers (Table 2) were designed based on the target gene sequence 
of M93Sm. A 250 or 401 bp DNA fragment of the 5’ region and the 3’ region of the 
target gene was PCR amplified and ligated using the Gibson assembly method into the 
suicide vector pDM4 (Table 1) previously digested with SphI or SacI [32]. The Gibson 
assembly mixture was introduced into E. coli SM10 by electroporation using a BioRad 
Gene Pulser II (BioRad, Hercules, CA). Transformants were selected on LB10 Cm20 agar 
plates. The construction of the recombinant pDM4 was confirmed by PCR amplification. 
The mobilizable suicide vector was transferred from E. coli SM10 into V. anguillarum by 
conjugation. Single-crossover transconjugants were selected with LB20 Sm200 Cm5 
plates, and subsequently, double-crossover transconjugants were selected with LB20 
Sm200 plates containing 5% sucrose. The resulting V. anguillarum mutants were checked 
for the desired allelic exchange by PCR amplification using primers (Table 2) flanking 
the deletion. 
Cell growth experiments. To cultivate cells for growth experiments, V. 
anguillarum cells grown overnight at 27°C in LB20 supplemented with the appropriate 
antibiotics were harvested by centrifugation (9,000 × g, 2 min), washed twice and 
resuspended in in NSS. A 200 µl aliquot of the V. anguillarum NSS suspension was 
transferred into a 96-well plate with a clear flat bottom and the optical density at 600 nm 
(OD600) was read by a VersaMax™ Absorbance Microplate Reader (Molecular Devices). 
The V. anguillarum NSS suspension was prepared to an OD600 between 0.400 and 0.500 
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(~4 × 107 CFU/ml) and diluted 1:100 into fresh media. Growth was monitored either by 
measurement of the OD600 or by serial dilution and plate counts. 
RNA isolation. Exponential phase cells (3.9×107 to 7.3×107 CFU/ml) of various V. 
anguillarum strains were treated with RNAprotect Bacteria Reagent (QIAGEN) 
following the manufacturer’s instructions. Total RNA was isolated using the RNeasy kit 
following the instructions of the manufacturer. All purified RNA samples were quantified 
spectrophotometrically by measuring absorption at 260 nm and 280 nm using a 
NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific) and overall quality 
was assessed by gel electrophoresis. Samples were stored at -75ºC for future use. 
Real-time quantitative RT-PCR (qRT-PCR). qRT-PCR was used to quantify various 
mRNAs using an LightCycler® 480 Real-Time PCR System (Hoffmann-La Roche Inc.) 
and the Brilliant II SYBR Green Single-Step QRT-PCR Master Mix (Agilent 
Technologies), with 10 ng of total RNA in 20 µl reaction mixtures. The thermal profile 
was 50°C for 30 min, 95°C for 15 min, and then 40 cycles of 95°C for 30 s and 55°C for 
30 s. Fluorescence was measured at the end of the 55°C stage of each cycle. Samples 
were run in triplicate along with the no-reverse-transcriptase control and the no-template 
control. All experiments were repeated twice. 
Fish infection experiments. Various V. anguillarum strains were tested for virulence 
against rainbow trout by immersion infection. Briefly, V. anguillarum cells grown for 19 
h at 27°C in LB20 supplemented with the appropriate antibiotics were harvested by 
centrifugation (6,000 × g, 10 min, 4°C), washed twice in NSS, and resuspended in NSS. 
The V. anguillarum NSS suspension was prepared to the desired specific cell density 
according to the conversion equation: Cell density (108 CFU/ml) = 44.905 × OD600. The 
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actual cell density of the suspension was confirmed by dilution and viable plate count. 
All fish were examined and determined to be disease and injury free prior to the start of 
each experiment. For immersion, 10 ml of V. anguillarum suspended in NSS, or 10 ml of 
NSS only as a negative control was added to a bucket filled with 10 L of water 
supplemented with 1.5% NaCl that was maintained at 18.5 ± 0.5ºC. Fish that were 
between 15 cm and 25 cm long were added and immersed for 1 h. For both methods, fish 
inoculated with different bacterial strains were maintained in separate 38 L or 191 L 
tanks to prevent possible cross-contamination with constant water flow (200 ml/min) at 
19 ± 1ºC. Death due to vibriosis was determined by the observation of gross clinical 
symptoms and confirmed by the recovery and isolation of V. anguillarum cells resistant 
to the appropriate antibiotics from the spleen or head kidney of dead fish. Observations 
were made for 7 days. All fish used in this research project were obtained from the 
Lafayette Trout Hatchery located in North Kingstown, Rhode Island. All fish infection 
protocols were approved by the URI IACUC. (IACUC Protocol AN06-08-002). 
Statistical analysis. Student's T-tests assuming unequal variances were used for 
statistical analyses for experiments containing two data groups. One-way ANOVA with 
repeated measures plus Tukey post hoc test was performed on bacterial growth curves. A 
Kaplan-Meier survival analysis with log rank significance test was performed on the 
survival percentage in the fish infection experiment. P values of <0.05 were considered 
statistically significant. 
Results 
ΔgltA mutant exhibited significant lower cell density limit than wild type in rich 
media and is auxotrophic for glutamate. Fig 1A shows a typical growth curve for the 
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wild type (M93Sm) and the ΔgltA mutant composed of a lag phase, exponential growth 
phase and stationary phase grown in a rich medium (dashed lines). Like the previously 
described icd mutant, the gltA mutant has a lower cell density limit rich media [28]. The 
gltA mutant is auxotrophic for glutamate because it cannot run the first half of the 
oxidative TCA cycle which is needed to synthesize the immediate precursor molecule for 
glutamate production, α-ketoglutarate (Fig 1B). When glutamate (118 mM final 
concentration) was added to LB20 (solid lines), the ΔgltA mutant grew to a wild type cell 
density (Fig 1A). 
ΔgltA mutant exhibited either same or higher expression levels of the three 
hemolysin genes compared to wild type. As previously described, M93Sm secretes 
three hemolysins, Vah1, RtxA, and Plp that are most strongly expressed during 
exponential phase [11]. The expression of vah1, rtxA and plp was tested by qRT-PCR 
during exponential phase to determine if the ΔgltA mutant would have altered expression 
of these hemolysin genes. While there was no statistically significant increase in 
expression (P values ranged from 0.08 to 0.42), the gltA mutant exhibited 1.3-fold greater 
rtxA expression, 1.9-fold greater plp expression and 3.7-fold greater vah1 expression 
compared to the wild type (Fig. 2).  
ΔgltA mutant was as virulent as the wild type against juvenile rainbow trout. Ten 
juvenile rainbow trout were challenged via immersion at doses of 3×106 to 4×106 
CFU/ml with the wild type (M93Sm) and the ΔgltA mutant. There was no significant 
difference in survival between M93Sm (10%) and the ΔgltA mutant (20%) (P = 0.31) 
(Table 3); however, it took three days for the ΔgltA mutant to reach 80% mortality 
compared to two days for 90% mortality in fish infected with M93Sm. While the data 
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strongly suggest that deleting gltA had a very small effect on virulence, the delay in 
mortalities raised the possibility that a mutation that compensated for the loss of citrate 
synthase was selected in the infected fish. 
A mutation in prpR allowed the ΔgltA mutant to grow in 3M + 0.15% glucose. In 
order to test for the possibility that a compensatory mutation that would bypass the ΔgltA 
mutation could have been selected, the ΔgltA mutant was grown in 3M + 0.15% glucose 
for multiple days. An Δicd mutant was also created and was unable to grow in 
3M+0.15% glucose (data not shown). The ΔgltA mutant began to grow after 48 h, 
reaching wild type levels by 72 h (Fig. 3). A frozen stock was created from the 72 h 
culture. A single colony, isolated from the frozen stock, was used for another growth 
experiment in 3M + 0.15% glucose. This new strain was able grow in 3M + 0.15% 
glucose during a 24 h incubation. When the gltA gene was sequenced from this strain, 
there was no change in the sequence from the original ΔgltA mutation; it remained 
truncated.  
It has previously been described that 2-methylcitrate synthase (PrpC), an enzyme 
that combines propionyl-COA and oxaloacetate to synthesize 2-methylcitrate, can act in a 
promiscuous manner and synthesize citrate from acetyl-CoA and oxaloacetate [34]. 
Accordingly, prpB (2-methylisocitrate lyase), prpC, prpR (transcriptional regulator) and 
the intergenic regions were sequenced using the primers listed in Table 2. A single 
nucleotide mutation was found in prpR that changed amino acid 66 from an arginine to a 
leucine. The wild type and the parental ΔgltA mutant did not have this mutation. No 
mutations were found in prpB, prpC or the intergenic regions. The spontaneous mutant 
was designated as ΔgltA prpR (R66L). 
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ΔgltA prpR(R66L) mutant has a higher expression level of prpC compared to wild 
type and the ΔgltA mutant. Digianantonio et al [35] demonstrated that increased 
expression of prpC enabled an E. coli ΔgltA mutant to grow on minimal media agar. 
Accordingly, the expression of prpC was measured by qRT-PCR during exponential 
phase to determine if the mutation found in the transcriptional regulator prpR of the 
ΔgltA prpR(R66L) mutant would cause an increase in expression of prpC. The ΔgltA 
prpR(R66L) mutant exhibited a 12- and 8-fold increase in expression compared to the 
wild type (M93Sm) and the ΔgltA mutant, respectively. These increases in prpC 
expression were statistically significant (P<0.01) demonstrating that the prpR(R66L) 
mutation caused an increase in expression of prpC (Fig. 4).  
The ΔgltA prpR(R66L) mutant grew to a higher total cell density in spleen extract 
medium compared to the ΔgltA mutant. The final cell densities (CFU/ml) were 
determined for the wild type (M93Sm), the ΔgltA mutant and the ΔgltA prpR(R66L) 
mutant after 24 h of growth in three forms of rich media: LB20, NSSM and NSS 
supplemented with spleen extract (Table 4). In LB20 and NSSM, both the ΔgltA mutant 
and the ΔgltA prpR(R66L) mutants grew to a total cell density that was statistically lower 
than M93Sm. The difference between the ΔgltA mutant and the ΔgltA prpR(R66L) 
mutant was not statistically significant. In the spleen extract medium, M93Sm grew to the 
highest cell density (7.7×107 CFU/ml) followed by the ΔgltA prpR(R66L) mutant 
(1.5×107 CFU/ml), while the ΔgltA mutant grew to 5.7×107 CFU/ml. The difference 
between M93Sm and the ΔgltA prpR(R66L) mutant was not statistically significant. The 
data strongly suggest that the ΔgltA prpR(R66L) mutant had a growth advantage in 
spleen extract medium compared to the ΔgltA mutant.  
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The prpR(R66L) mutation in the ΔgltA mutant can be selected for in spleen extract 
medium. The wild type (M93Sm), the ΔgltA mutant and the ΔgltA prpR(R66L) mutant 
were grown in spleen extract medium for multiple days (Fig. 5). By 96 h, number of 
viable cells in the cultures of both M93Sm and the ΔgltA prpR(R66L) mutant began to 
decline. However, the cell density of the ΔgltA mutant increased between 96 h and 120 h. 
Colonies were chosen at random from the ΔgltA mutant 120 h agar plate and screened to 
ensure that the ΔgltA mutation was still deleted and if the colonies could grow in 3M + 
0.15% glucose. All colonies had the truncated version of gltA while 4 out of the 6 
colonies grew in 3M + 0.15% glucose with only a 24 h incubation. Although, it was not 
screened, the ability to grow 24 h in minimal media (Fig. 5) was presumably from a 
mutation in prpR. The data suggest that the prpR(R66L) mutation in the ΔgltA mutant 
strain is favored in spleen extract medium. 
ΔgltA ΔprpC mutant is unable to grow in 3M + 0.15% glucose and grows to a lower 
cell density limit in two forms of rich media. A ΔprpC mutant and a ΔgltA ΔprpC 
mutant were created and their growth was examined. After 24 h, the ΔgltA ΔprpC mutant 
grew to a lower cell density in LB20 compared to the wild type (M93Sm) (Fig. 6A) and 
failed to grow in 3M + 0.15% glucose after 192 h (Fig. 6B). Growth in spleen extract 
medium was monitored and after 210 h the ΔgltA ΔprpC mutant failed to grow to the cell 
density of M93Sm or the ΔgltA mutant (Fig. 6C). The ΔprpC mutant grew to a wild type 
cell density in all forms of media (Fig. 6). The data demonstrate that when prpC is 
deleted in the ΔgltA mutant, the bacteria are no longer able to grow in 3M+0.15% 
glucose and lose their growth advantage in spleen extract media. However, the loss of 
prpC alone had little effect on growth.  
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ΔgltA ΔprpC double mutant is as virulent as the wild type against juvenile rainbow 
trout. Five to nine juvenile rainbow trout were challenged via immersion at a dose of 
4×106 CFU/ml to 6×106 CFU/ml with either the wild type (M93Sm), the ΔprpC mutant, 
or the ΔgltA ΔprpC mutant. Fish infected with either M93Sm or the prpC mutant had 0% 
survival after 3 and 2 days, respectively (Table 5). While fish infected with the ΔgltA 
ΔprpC mutant had 22% survival, there was no significant difference in survival between 
M93Sm (0%) and the ΔgltA ΔprpC mutant (P = 0.23). The data suggest that deleting 
both gltA and prpC causes only a small attenuation of virulence. 
Discussion 
Citrate synthase catalyzes the first of eight reactions in the generation of energy 
through the oxidation of acetate by the tricarboxylic acid (TCA) cycle. TCA 
intermediates also serve as precursor metabolites for the synthesis of amino acids and 
peptidoglycan. Specifically, this investigation focused on the inability of the ΔgltA 
mutant to produce the TCA cycle intermediate and immediate precursor to glutamate 
synthesis, α-ketoglutarate. Previously, a V. anguillarum icd mutant was shown to be both 
highly attenuated in virulence and immunoprotective in juvenile rainbow trout [28]. The 
loss of pathogenicity was hypothesized to have resulted from the inability to synthesize 
glutamate; the cells would stop replicating and be prevented from reaching the threshold 
needed to cause systemic infection after they exhausted glutamate from their host. 
Aromatic compound auxotroph mutants have been demonstrated to be highly attenuated 
since the 1980s [12-16]. More recent studies have demonstrated that intracellular 
pathogens containing TCA cycle mutations are attenuated for virulence if the specific 
mutations prevent growth using the available nutrients in the nutrient-poor phagosome 
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[17-27]. Since V. anguillarum is not an intracellular pathogen and cannot survive in 
macrophages, it would not be subject to this type of nutrient limitation [36]. Additionally, 
the initial infection site V. anguillarum M93Sm, an O2α serotype, is presumably the 
intestines (external necrotic lesions have never been observed in fish exposed to this 
strain, unpublished observations) where it grows in the glutamate rich intestinal mucus 
[7, 8, 37]. Therefore, the previously described link between glutamate auxotrophy and 
attenuation in virulence in M93Sm warranted further investigation [28].  
A ΔgltA strain was created and showed the same growth phenotype as the 
previously described icd mutant (Fig. 1) [28]. Unlike the icd mutant, the gltA mutant was 
as virulent as the wild type against juvenile rainbow trout. However, death from systemic 
infection was delayed by about 1 day (Table 3) suggesting that a compensatory mutation 
that could bypass the citrate synthase deletion was being selected for in the ΔgltA mutant. 
Indeed, a ΔgltA strain capable of growth in 3M + 0.15% glucose media (a medium in 
which it should fail to grow) was isolated (Fig. 3). When this ΔgltA strain was sequenced 
a spontaneous mutation was found in prpR, the transcriptional activator of 2-
methylcitrate synthase (prpC), that changed arginine 66 to a leucine (this strain was 
named ΔgltA prpR(R66L)). The normal enzymatic function of PrpC is to synthesize 2-
methylcitrate from propionyl-CoA and oxaloacetate; however, it has been demonstrated 
that PrpC can act promiscuously, substituting acetyl-CoA for propionyl-CoA to 
synthesize citrate [34]. The ability of the ΔgltA prpR(R66L)) mutant to grow in 3M + 
0.15% glucose media resulted from an increase in expression of prpC (Fig. 4). The 
increase in expression of prpC enabled the cells to bypass the gltA deletion, an 
observation previously described in an E. coli ΔgltA strain by Digianantonio et al [35]. 
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The hypothesized route of infection for V. anguillarum M93Sm is through the 
anus of the fish where it damages the lining of gastrointestinal tract to enter the 
circulatory system where it accumulates in the spleen [7, 8]. Accordingly, the in vitro 
growth of the ΔgltA prpR(R66L) mutant was characterized in NSSM and spleen extract 
medium to represent the environment of early and mid-stage infections respectively 
(LB20 served as a control). The growth advantage of the ΔgltA prpR(R66L) mutant in 
spleen extract medium coupled with the isolation of spontaneous prpR mutants in the 
ΔgltA mutant after extended growth in spleen extract medium suggest that during 
infection with the ΔgltA mutant, mutations in prpR are selected for in the fish spleen 
allowing the ΔgltA mutant to cause systemic infection. To test this idea, a ΔgltA ΔprpC 
mutant was created and was shown to be unable to grow in minimal media and had no 
growth advantage in spleen extract. Surprisingly there was no statistically significant 
difference in survival in fish challenged with the wild type and the ΔgltA ΔprpC mutant 
indicating that glutamate auxotrophy in and of itself may not necessarily result in 
attenuation. 
The data presented here suggest that our previously proposed hypothesis that 
simple starvation for glutamate results in attenuation of virulence must be modified. 
While the small decrease in mortality during infection of the ΔgltA ΔprpC mutant 
suggests glutamate auxotrophy may contribute to attenuation, it may not be the single 
cause of attenuation in virulence of the icd mutant. The oxidative branch of the TCA 
cycle is at the intersection of three regulatory molecules: acetyl-CoA, citrate and α-
ketoglutarate. Citrate accumulation has been shown to be detrimental to the growth rate 
and growth yield of E. coli with spontaneous citrate synthase mutants outgrowing icd or 
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aconitase (acnA and acnB) double mutants during in vitro growth experiments in 
complex media [38, 39]. Additionally, in Staphylococcus aureus, citrate has been shown 
allosterically activate CcpE, a regulator of metabolism and virulence factors [40]. An E. 
coli icd mutant was shown to have increased expression of the glyoxylate shunt causing 
lower acetyl-CoA production [41]. During acetogenesis, phosphotransacetylase converts 
acetyl-CoA into acetyl-P, a global regulator that is used to phosphorylate two-component 
signal transduction pathways [42]. Acetyl-P has been shown to induce virulence factor 
expression in V. cholerae, S. enterica and E. coli [43-46]. Further, acetyl-CoA 
accumulation alone, without being converting to acetyl-P, was shown to cause increased 
expression of the V. cholerae virulence gene activator ToxT [47]. Lastly, α-ketoglutarate 
has been shown to be a master regulator that coordinates nitrogen and carbon metabolism 
by inhibiting the production of cyclic AMP and has been shown to regulate virulence 
factors in UPEC [48-50]. Mutations in gltA or icd in V. anguillarum would result in 
altered intracellular levels of acetyl-CoA, citrate and α-ketoglutarate. The phenotype of 
the icd mutant (low intracellular levels of acetyl-CoA and high intracellular levels of 
citrate) could be causing the attenuation of virulence against juvenile rainbow trout 
because the cells can no longer sense their metabolic environment and consequently 
cannot properly coordinate the expression of appropriate virulence factors in vivo.  
While expression levels of the three hemolysins in the icd and ΔgltA mutants have 
been examined and shown to be the same or higher compared to their expression wild 
type M93Sm cells in vitro, (Fig. 4) expression of other virulence factors important for 
systemic infection and persistence (the chemotaxic system, protease production, 
lipopolysaccharides production, iron acquisition, and flagella synthesis) have not been 
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examined and could be effected by the intracellular concentrations of acetyl-CoA, citrate, 
or α-ketoglutarate [28]. Further studies examining the entire transcriptome may reveal 
whether other potential virulence factors are affected by mutations in icd or gltA in V. 
anguillarum. 
Conclusion 
 A V. anguillarum ΔgltA strain was created and was demonstrated to be similar to 
the previously described icd mutant; both strains demonstrated a decreased final cell 
density in multiple forms of rich media and had expression of hemolysin genes that was 
similar to the wild type. Unlike the icd mutant, the ΔgltA mutant was as virulent as the 
wild type in juvenile rainbow trout. Spontaneous mutations arose in prpR that caused an 
increase in expression of the promiscuous enzyme prpC allowing the ΔgltA mutant to 
bypass the gltA deletion and grow in minimal media and have a growth advantage in 
spleen extract media. A ΔgltA ΔprpC mutant was created and was demonstrated to be 
unable to grow in minimal media and no longer have a growth advantage in spleen 
extract media. However, the ΔgltA ΔprpC mutant exhibited only a slight attenuation in 
virulence compared to the wild type against rainbow trout further suggesting that simple 
starvation for a required nutrient (i.e. glutamate) will not directly result in attenuation of 
virulence as previously proposed. 
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Table 1 Bacterial strains and plasmids used in this study 
Strain or plasmid Description Reference 
V. anguillarum 
strains 
    
M93Sm Spontaneous Smr mutant of M93 (serotype O2a) [51] 
ES496 Smr; gltA deletion mutant This study 
ES3-2 
Smr; gltA deletion mutant, spontaneous mutation in prpR 
(R66L) 
This study 
ES6600 Smr; prpC deletion mutant This study 
ES496.6600 Smr; gltA prpC double mutant This study 
E. coli strains 
  
Sm10 thi thr leu tonA lacY supE recA RP4-2-Tc::Mu::Km (λ pir) [52] 
Q496 Kmr Cmr; Sm10 containing plasmid pDM4-gltA5’-gltA3’ This study 
Q6600 Kmr Cmr; Sm10 containing plasmid pDM4-prpC5’-prpC3’ This study 
Plasmid 
  
pDM4 Cmr Kmr SacBCr; suicide vector  [30] 
pDM4-gltA5’-gltA3’ Cmr SacBCr; For gltA deletion mutant This study 
pDM4-prpC5’-prpC3 Cmr SacBCr; For prpC deletion mutant This study 
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Table 2. Primers used in this study 
Primer 
Sequence (5'to3', lowercase sequences are 
designed to be homologous to flanking 
sequences) 
Description1 Reference 
PmG-01 
caggttacccgcatgAGCTGCCGATTATGGATGG
G 
For gltA GA 5' region, forward This study 
PmG-02 ggaatgttaAAGTGAATCATGGTAGAACGCGG For gltA GA 5' region, reverse This study 
PmG-03 
gattcacttTAACATTCCTGAGTATGTGGTCAGA
GC 
For gltA GA 3' region, forward This study 
PmG-04 
ctagatagatcttgcatgGGCCAGTATAAAGTTGAC
GAGGTC 
For gltA GA 3' region, reverse This study 
PmG-23 aatcccgggagagctAACGCACCACTGGGCGGC 
For prpC GA 5' region, 
forward 
This study 
PmG-24 tgaccaacGCCGGTGCGCATTACGTCC 
For prpC GA 5' region, 
reverse 
This study 
PmG-25 
gcaccggcGTTGGTCAAAAGCGTTATCTGAAG
C 
For prpC GA 3' region, 
forward 
This study 
PmG-26 
cgggtaacctgagctTTAACGCTGCTCTATTGGTA
TCCAC 
For prpC GA 3' region, 
reverse 
This study 
PmG-27 GCTCGATAGCATGCAAACCCGT For prpB sequencing, forward This study 
PmG-28 CCGACAATCTGCAGCGGATCAT For prpB sequencing, reverse This study 
PmG-29C CTGCTCTATTGCCGTGCGAA For prpC checking, forward This study 
PmG-30C CGAGATCGCGCTTACGCTCA For prpC checking, reverse This study 
Pm112s AGCCCGATATCGCGCAGTTAAATG For gltA checking, forward This study 
Pm117 TTCTTCTGGTGCTAACCCGTTTG For gltA sequencing This study 
Pm118 GCTCTCGGAGAATGGTTAGCGA For gltA checking, reverse This study 
vah1F RT GTTTGGTATGGAACACCGCTCAAG For vah1 qRT-PCR, forward [28] 
vah1R RT GGCTCAACCTCTCCTTGTAACCAA For vah1 qRT-PCR, reverse [28] 
plp F RT CAGACGACCACCAGTAACCACTAA For plp qRT-PCR, forward [5] 
plp R RT GCAATCATGATGACCCAGCAACAG For plp qRT-PCR, reverse [5] 
Pm111 GGAAATTATTCCGCCGACGATGGA For rtxA qRT-PCR, forward [4] 
Pm112 GCCGATACCGTATCGTTACCTGAA For rtxA qRT-PCR, reverse [4] 
Pm132 TTATGTACTGTCGGAAAAACTGGG For prpC qRT-PCR, forward This study 
Pm133 TGGTCAAGTTCACTTTGATTAGGT For prpC qRT-PCR, reverse This study 
1GA; Gibson Assembly 
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Table 3 Virulence of V. anguillarum strains in juvenile rainbow trout
1
 
Strain Dosage (CFU/ml)2 Total Mortality 
No. of days until 
death (No. of fish / 
total) 
M93Sm 4×10
6
 90% 1 (3/10) 2 (9/10) 
ΔgltA 3-4×10
6
 80% 
1 (1/10) 2 (6/10) 3 
(8/10) 
Control (NSS) 
 
0% NA 
1 
Sum of two treatments, five fish per treatment 
2 ΔgltA dosage: first treatment (3 ×106), second treatment (4 ×106) 
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Table 4 Final CFU/ml (±S. D) of various V. anguillarum cultures grown for 24 h1 
Strain CFU/ml in LB20 
CFU/ml in NSSM (200 
µg/ml) 
CFU/ml in spleen 
extract (100 µg/ml) 
M93Sm 3.4 (±0.3) ×109 [1.00] 4.2 (±1.0) ×109 [1.00] 7.7 (±2.1) ×107 [1.00] 
ΔgltA 1.6 (±0.1) ×109 [0.47]** 1.2 (±0.2) ×109 [0.29]* 1.5 (±0.05) ×107 [0.19]* 
ΔgltA 
prpR(R66L) 
1.5 (±0.09) ×109 
[0.45]** 
1.5 (±0.2) ×109 [0.36]* 5.7 (±0.4) ×107 (0.74) 
S.D = standard deviation 
1Values in brackets represent growth percentage compared to wild type.  
** statistically significant to wild type (P < 0.01), * statistically significant to wild type (P < 0.05)  
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Table 5 Virulence of V. anguillarum strains in juvenile rainbow trout 
Strain Dosage (CFU/ml) Total Mortality 
No. of days until 
death (No. of fish / 
total) 
M93Sm 5×106 100% 1 (6/9) 2 (8/9) 3 (9/9) 
ΔprpC 6×106 100% 1 (2/5) 2 (5/5) 
ΔgltA ΔprpC 4×106 78% 1 (4/9) 2 (6/9) 3 (7/9) 
NSS 
 
0% 3 (1/5)* 
*Death was not caused by vibriosis 
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Figure 1. Growth of V. anguillarum WT (M93Sm) and the gltA mutant under various 
conditions. A) Growth curves of V. anguillarum M93Sm (black) and the gltA mutant 
(blue) in LB20 (dashed lines) or LB20 supplemented with 118 mM glutamate (solid 
lines). B) Final cell densities (OD
600
) of V. anguillarum strains after 24 h of growth in 3M 
plus 0.15% glucose supplemented with or without 5.9 mM glutamate. In each experiment 
cells grown overnight in LB20 were washed twice in NSS, calibrated to an OD
600
 
between 0.4 and 0.5 and used to inoculate the appropriate media at a 1:100 dilution. 
Cultures were incubated at 27
o
C in a shaking water bath (200 rpm) and at various time 
points after inoculation samples were taken for determination of optical density at 600 
nm (OD
600
). The data are the average of two independent experiments. Different letters 
indicate statistical significance among groups (P < 0.05). Statistical analysis was based 
on data at 24 h. Between marked strains and M93Sm: ** P < 0.01. Error bars represent 1 
standard deviation. 
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Figure 2. Expression of vah1, rtxA, and plp determined by qRT-PCR analysis of V. 
anguillarum wild-type (M93Sm) and the gltA mutant during logarithmic (Log)-phase 
growth. The data presented are the averages of two independent experiments. Each value 
is the average for six replicates. Error bars represent 1 standard deviation.  
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Figure 3. Growth curves of various V. anguillarum strains grown in 3M + 0.15% glucose 
at 27°C with shaking (200 rpm). At various time points after inoculation samples were 
taken for determination of optical density at 600 nm (OD600). In each experiment cells 
grown overnight in LB20 were washed twice in NSS, calibrated to an OD600 between 0.4 
and 0.5 and used to inoculate the appropriate media at a 1:100 dilution. Cultures were 
incubated at 27oC in a shaking water bath (200 rpm) and at various time points after 
inoculation samples were taken for determination of optical density at 600 nm (OD600). 
The data are the average of two independent experiments. Error bars represent 1 standard 
deviation.  
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Figure 4. Expression of prpC determined by qRT-PCR analysis of V. anguillarum wild-
type (M93Sm), the gltA mutant and the gltA mutant with the spontaneous mutation in 
prpR(R66L) during logarithmic (Log)-phase growth. The data presented are the averages 
of two independent experiments. Each value is the average of six replicates. Between 
marked strains and M93Sm: ** P < 0.01. Error bars represent 1 standard deviation.  
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Figure 5. Growth curves of various V. anguillarum strains grown in in NSS + spleen 
extract (100µg/ml) at 27°C with shaking (200 rpm). The data are a representative of two 
independent experiments. At various time points after inoculation samples were taken for 
determination CFU/ml by serial dilution and spot plating. In each experiment cells grown 
overnight in LB20 were washed twice in NSS, calibrated to an OD600 between 0.4 and 0.5 
and used to inoculate the appropriate media at a 1:100 dilution. ΔgltA colonies were 
picked from the 120 h plate and used to inoculate 3M + 0.15% glucose. In addition, 
colony PCR using primers flanking gltA was performed to ensure gltA was still deleted. 
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Figure 6. Growth curves of various V. anguillarum strains grown in in various conditions 
at 27°C with shaking (200 rpm). A) Final cell densities (OD600) of V. anguillarum strains 
after 24 h of growth in LB20. B) Growth curves of various V. anguillarum strains grown 
in 3M + 0.15% glucose at 27°C with shaking (200 rpm). C) Growth curves of various V. 
anguillarum strains grown in spleen extract medium at 27°C with shaking (200 rpm). 
ΔgltA colonies were picked from the 120 h plate, screened to ensure gltA was still deleted 
by colony PCR using primers flanking gltA and were used to inoculate 3M + 0.15% 
glucose. At various time points after inoculation samples were taken for determination of 
CFU/ml by serial dilution and spot plating or for determination of optical density at 600 
nm (OD600). In each experiment cells grown overnight in LB20 were washed twice in 
NSS, calibrated to an OD600 between 0.4 and 0.5 and used to inoculate the appropriate 
media at a 1:100 dilution. The data for A and B are the average of two independent 
experiments. Different letters indicate statistical significance among groups (P < 0.05). 
Statistical analysis was based on data at 24 h. Error bars represent 1 standard deviation. 
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Abstract 
Background: There are twenty-three serotypes of the marine pathogen Vibrio 
anguillarum¸ three of which are responsible for causing warm water vibriosis, a fatal 
hemorrhagic septicemic disease of fish. A previous study demonstrated that a V. 
anguillarum M93Sm (O2a serotype) icd mutant was attenuated in virulence; however, it 
is not known if mutating this gene in the O1 serotype V. anguillarum NB10Sm will result 
in the same phenotype.  
Results: A V. anguillarum NB10Sm icd mutant was created, characterized for growth in 
complex media and demonstrated to be as virulent as the wild type. Several additional 
central metabolism single and double mutants were created in the following genes cra, 
gltA, Δicd gltA, sucA, sucC, sdhC, ΔfrdA, ΔfrdA sdhC, and fumA and characterized with 
regard to growth in complex media. Two mutants (ΔsucA and ΔfrdA ΔsdhC) that 
demonstrated a significantly reduced growth yield compared to the wild type were further 
characterized with regard to their growth is several forms of complex media, expression 
of virulence genes, and virulence in juvenile rainbow trout (Oncorhynchus mykiss). 
Conclusions: The data strongly suggest that there is no correlation between a lower 
growth yield in vitro and a decrease in virulence in vivo. Even though M93Sm and 
NB10Sm are same species, mutations made in the same TCA cycle genes can cause 
drastically difference results in regards to growth and virulence. 
Keywords: Vibrio anguillarum, TCA cycle, vibriosis, virulence, hemolysin, protease 
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Background 
 Vibrio anguillarum is a causative agent of warm water vibriosis, which causes a 
fatal hemorrhagic septicemic disease of fish, as well as morbidity and mortality in 
crustaceans and bivalves [1-3]. Mortality rates from vibriosis range between 30 to 100% 
and contribute to significant economic losses to the aquaculture industry worldwide [1, 
3]. Typically, the initial site of infection is the skin, gills or intestines and in vivo studies 
have demonstrated that death from system infection usually occurs 1-4 days post 
infection [4-9]. Numerous virulence factors that have been shown to be important during 
infection include extracellular proteases, hemolytic cytotoxins, iron acquisition systems 
(siderophores), lipopolysaccharides, chemotaxis, and flagella [10]. 
Previously, a V. anguillarum M93Sm icd mutant was shown to be highly 
attenuated against juvenile rainbow trout and immunoprotective [11]. Auxotrophic or 
TCA cycle mutants attenuated in virulence have been created in several intracellular 
bacteria species [12-27]. The attenuation of the V. anguillarum M93Sm mutant was 
hypothesized to have resulted from the mutant being unable to grow to a final wild type 
cell density. The decreased growth yield resulted from the cells being auxotrophic and 
starved for glutamate [11]. If this same growth limitation were to occur during an 
infection, the cells would not be able to surpass threshold needed to cause disease. 
Interestingly, unlike the previously reported attenuated auxotrophic or TCA cycle 
mutants, V. anguillarum is not an intracellular pathogen and would not be experience the 
nutrient limitations of the phagosome [28]. Accordingly, glutamate auxotrophy may not 
be the single cause of the attenuation of the icd mutant as a later study demonstrated that 
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another mutant auxotrophic for glutamate (ΔgltA) was as virulent as the wild type 
[Spinard, EJ et al, in preparation, chapter 2 of this manuscript].  
There are twenty-three serotypes of V. anguillarum (O1-O23) that have been 
differentiated by O-serotyping; only three serotypes (O1-O3) are important pathogens in 
fish [29, 30]. M93Sm is a spontaneous streptomycin resistant mutant selected from an 
O2a serotype strain originally isolated from a diseased ayu (Plecoglossus altivelis) from 
Lake Biwa in Japan [31]. Even though the M93Sm icd mutant stimulated an adaptive 
immune response that protected the fish from a subsequent M93Sm wild type challenge, 
it may be necessary to create a multivalent vaccine in order to promote full 
immunoprotection against multiple serotypes of V. anguillarum. In the late 1980s, salmon 
reared in New Brunswick vaccinated with bacterins composed of V. anguillarum serotype 
O1 and V. ordalii later died from vibriosis caused by V. anguillarum O2 serotypes; 
addition of an O2 bacterin reduced death from V. anguillarum O2 serotype induced 
vibriosis [32]. Accordingly, this study focused on creating and characterizing the growth 
and virulence of central metabolism mutants in V. anguillarum NB10Sm (spontaneous 
streptomycin resistant O1 serotype strain originally isolated from a rainbow trout near the 
city of Boden, Sweden) with the goal of creating a live attenuated O1 strain [33].  
Methods 
Bacterial strains, plasmids, and growth conditions. V. anguillarum strains (Table 1) 
were routinely grown in Lysogeny broth containing 2% NaCl (LB20) [34], LB20 
containing various additional supplements, Marine Minimum Median (3M) + 0.15% 
glucose [35], NSS supplemented with fish gastrointestinal mucus (NSSM), NSS 
supplemented with fish skin mucus (NSSSkM) or NSS Spleen extract medium 
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supplemented with the appropriate antibiotic, in a shaking water bath at 27°C. E. coli 
strains (Table 1) were routinely grown in Lysogeny broth containing 1% NaCl (LB10) 
supplemented with the appropriate antibiotic, in a shaking water bath at 37°C. Antibiotics 
were used at the following concentrations: streptomycin, 200 g/ml (Sm200); 
chloramphenicol, 20 g/ml (Cm20) for E. coli and 5 g/ml (Cm5) for V. anguillarum; 
40g/ml (Km40) kanamycin for liquid media or 80g/ml (Km80) kanamycin for solid 
media for V. anguillarum and E. coli. 
Insertional mutagenesis. Insertional mutations in the target genes: icd, sucA, sucC, 
sdhC, fumA and cra were created by using previously constructed suicide vectors [11]. 
Additional insertional mutations were made by using a modification of the procedure 
described by Milton et al. [36]. Briefly, primers (Table 2) were designed based on the 
target gene sequence of NB10. A 200-300 bp DNA fragment of the target gene was PCR 
amplified and ligated into the suicide vector pNQ705-1 (Table 1) after digestion with 
SacI and XbaI. The ligation mixture was introduced into E. coli SM10 by electroporation 
using a BioRad Gene Pulser II (BioRad, Hercules, CA). Transformants were selected on 
LB10 Cm20 agar plates. The construction of the recombinant pNQ705 was confirmed by 
PCR amplification. The mobilizable suicide vector was transferred from E. coli SM10 
into V. anguillarum by conjugation [37]. Transconjugants were selected by utilizing the 
chloramphenicol resistance gene located on the suicide plasmid. The incorporation of the 
recombinant pNQ705 was confirmed by PCR amplification. 
Allelic exchange mutagenesis. Deletion mutations were made by using a modification of 
the procedure described by Milton et al. [36]. Suicide vectors were constructed via 
restriction enzyme digestion/ligation (frdA, sucA, icd, CUO) or Gibson Assembly (sdhC). 
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Briefly, primers (Table 2) were designed based on the target gene sequence of NB10 
(Accession numbers: NZ_LK021130.1, NZ_LK021129.1 and NZ_LK021128.1). For 
restriction enzyme digestion and ligation, a DNA fragment of the 5’ region of the target 
gene varying in size from 297 to 425 bp was PCR amplified and ligated into the suicide 
vector pDM4 (Table 1) after digestion with SacI and XbaI. Subsequently a section of the 
3’ region of the target gene varying in size from 273 to 484 bp was PCR amplified and 
ligated into the suicide vector pDM4 containing the previously added 5’ region after 
digestion with XhoI and NheI. Finally, the kanamycin resistance cassette was amplified 
and ligated into the previously constructed suicide vector after digestions with XbaI and 
XhoI. For the Gibson Assembly method [38], primers (Table 2) were designed based on 
the target gene sequence of NB10. A 100 bp DNA fragment of the 5’ region and the 3’ 
region of the target gene was PCR amplified and ligated using the Gibson assembly 
method into the suicide vector pDM4 (Table 1) previously digested with SacI. The 
ligation or the Gibson Assembly mixture was introduced into E. coli SM10 by 
electroporation using a BioRad Gene Pulser II (BioRad, Hercules, CA). Transformants 
were selected on LB10 Cm20 agar plates. The construction of the recombinant pDM4 was 
confirmed by PCR amplification. The mobilizable suicide vector was transferred from E. 
coli SM10 into V. anguillarum by conjugation. Single-crossover transconjugants were 
selected with LB20 Sm200 Cm5 Km80 plates, and subsequently, double-crossover 
transconjugants were selected with LB20 Sm200 Km80 plates containing 5% sucrose. The 
resulting V. anguillarum mutants were checked for the desired allelic exchange by PCR 
amplification using primers (Table 2) flanking the deletion. 
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Cell growth experiments. V. anguillarum cells grown overnight at 27°C in LB20 
supplemented with the appropriate antibiotics were harvested by centrifugation (9,000 
× g, 2 min), washed twice and resuspended in in NSS. A 200 µl aliquot of the V. 
anguillarum NSS suspension was transferred into a 96-well plate with a clear flat bottom 
and the optical density at 600 nm (OD600) was read by a VersaMax™ Absorbance 
Microplate Reader (Molecular Devices). The V. anguillarum NSS suspension was 
prepared to an OD600 between 0.300 and 0.350 (~1.5 × 10
9 CFU/ml) and diluted 1:100 
into fresh media. Growth was monitored either by measurement of the OD600 or by serial 
dilution and plate counts. 
Fish infection experiments. Various V. anguillarum strains were tested for virulence 
against rainbow trout by immersion infection. Briefly, V. anguillarum cells grown for 20 
h at 27°C in LB20 supplemented with the appropriate antibiotics were harvested by 
centrifugation (6,000 × g, 10 min, 4°C), washed twice in NSS, and resuspended in NSS. 
The V. anguillarum NSS suspension was prepared to the desired specific cell density 
according to the conversion equation derived from Supplementary Figure 1: Cell density 
= (5 × 109 × OD600) – 4 × 107. The actual cell density of the suspension was confirmed by 
dilution and viable plate count. All fish were examined and determined to be disease and 
injury free prior to the start of each experiment. For immersion, 10 ml of V. anguillarum 
suspended in NSS, or 10 ml of NSS only as a negative control was added to a bucket 
filled with 10 L of water supplemented with 1.5% NaCl that was maintained at 19.5 ± 
0.5ºC. Fish that were between 15 cm and 25 cm long were added and immersed for 1 h. 
For both methods, fish inoculated with different bacterial strains were maintained in 
separate 191 L tanks to prevent possible cross-contamination with constant water flow 
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(200 ml/min) at 19 ± 1ºC. Death due to vibriosis was determined by the observation of 
gross clinical symptoms and confirmed by the recovery and isolation of V. 
anguillarum cells resistant to the appropriate antibiotics from the spleen or head kidney 
of dead fish. Observations were made for 7 days. All fish used in this research project 
were obtained from the Lafayette Trout Hatchery located in North Kingstown, Rhode 
Island. All fish infection protocols were approved by the URI Institutional Animal Care 
and Use Committee (IACUC) (IACUC Protocol AN06-08-002). 
RNA isolation. Exponential phase cells (~3 × 108 CFU/ml) or stationary phase cells (1.0 
× 109 to 7.8 × 109 CFU/ml) of various V. anguillarum strains were treated with 
RNAprotect Bacteria Reagent (QIAGEN), following the manufacturer’s instructions. 
Total RNA was isolated using the RNeasy kit following the instructions of the 
manufacturer. All purified RNA samples were quantified spectrophotometrically by 
measuring absorption at 260 nm and 280 nm using a NanoDrop ND-1000 
spectrophotometer (Thermo Fisher Scientific) and overall quality was assessed by gel 
electrophoresis. Samples were stored at -75ºC for future use. 
Real-time quantitative RT-PCR (qRT-PCR). qRT-PCR was used to quantify various 
mRNAs using an LightCycler® 480 Real-Time PCR System (Hoffmann-La Roche Inc.) 
and the Brilliant II SYBR Green Single-Step QRT-PCR Master Mix (Agilent 
Technologies), with 10 ng of total RNA in 20 µl reaction mixtures [7]. The thermal 
profile was 50°C for 30 min, 95°C for 15 min, and then 40 cycles of 95°C for 30 s and 
55°C for 30 s. Fluorescence was measured at the end of the 55°C stage of each cycle. 
Samples were run in triplicate along with the no-reverse-transcriptase control and the no-
template control. All experiments were repeated twice. 
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Statistical analysis. Student's T-tests assuming unequal variances were used for 
statistical analyses for all experiments except for the fish infection experiment. P values 
of <0.05 were considered statistically significant). A Kaplan-Meier survival analysis with 
log rank significance test was performed on the survival percentage in the fish infection 
experiment. P values of <0.05 were considered statistically significant. 
Results 
icd mutant grew to the same cell density limit as wild type in complex media. A V. 
anguillarum M93Sm icd mutant was previously shown to grow to a lower cell density 
than the wild type in nutrient rich media (e.g. LB20 and NSSM) [11]. A V. anguillarum 
NB10Sm icd insertional mutant was constructed and Fig. 2A shows a typical growth 
curve for the wild type (NB10Sm) and the icd mutant. Unlike the previously described 
M93Sm icd mutant, the NB10Sm icd had a slower growth rate during mid and late 
exponential phase growth compared to the wild type but reached the same cell density 
after growth for 24 h (Table 3, Supplementary Fig. 4) [11]. No additional copies of icd 
are found in the genome and the NB10Sm icd mutant was unable to grow in minimal 
media indicating that there is no promiscuous enzyme that can act as an isocitrate 
dehydrogenase (Fig. 2B). To ensure the icd insertional mutant (a merodiploid) did not 
resolve to restore the wild type, an icd deletion strain was created and showed no 
difference in growth compared to the icd insertional mutant (Fig. 2C). The data suggest 
that unlike the M93Sm icd mutant, the NB10Sm icd mutant can obtain enough α-
ketoglutarate derivatives (e.g. glutamate, glutamine, and peptides containing those amino 
acids) from LB20 to grow to a wild type final cell density. 
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icd mutant exhibits at a wild type growth rate when LB20 is supplemented with 
gluconate or glutamate. Fig. 3 shows the typical growth curve of the wild type 
(NB10Sm) (black) and the icd mutant (blue) in LB20 not supplemented (Fig. 3, dashed 
lines) or supplemented with 101.7 mM gluconate (Fig. 3A, solid lines) or 118 mM 
glutamate (Fig. 3B, solid lines). The data indicate that the icd mutant exhibited a growth 
rate during the mid and late exponential growth phases similar to the wild type when 
LB20 was supplemented with a metabolite that feeds into central metabolism upstream 
(gluconate) or downstream (glutamate) of the icd mutation (Table 3). Interestingly, the 
wild type grew to a higher cell density than the icd mutant when LB20 was supplemented 
with gluconate. The data suggests that under these conditions the icd mutant will utilize 
gluconate to grow rapidly but will experience a cell density limitation when the cells 
exhaust the available glutamate. 
 A ΔCUO icd mutant has the same growth phenotype as the icd mutant. The CUO 
(citrate utilization operons) is a ~17.9 kbp region of the NB10 genome, consisting of 
multiple genes and operons: a citrate lyase operon (accession numbers: 
WP_013856981.1, WP_013856980.1, WP_013856979.1 ), an ACP synthase (accession 
number: WP_013856979.1), an oxaloacetate decarboxylase operon (accession numbers: 
WP_013856986.1 and WP_029189993.1), a chemotaxis protein and kinase (accession 
number: WP_013856983.1 and WP_013856984.1), and a tri-carboxylate importer operon 
(accession numbers: WP_013856993.1, WP_019281353.1, and WP_013856991.1). The 
CUO is not present in the M93Sm genome and may provide an alternative to the 
glyoxylate shunt to prevent the intracellular buildup of citrate. Interestingly, the upstream 
genes (accession numbers: WP_013856977.1, WP_017049831.1, WP_019282875.1, and 
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WP_019282876.1) and downstream genes (accession numbers: WP_017046166.1 and 
ASO29090.1) flanking this region in the NB10Sm genome are homologous to 
neighboring genes in the M93Sm genome indicating an occurrence of a gain of function 
(NB10Sm) or loss of function (M93Sm) (Supplementary Fig. 2). The CUO region was 
deleted to determine if it enabled the NB10Sm icd mutant grow to a final cell density that 
was similar to the wild type. Fig. 4 shows a typical growth curve of the wild type 
(NB10Sm), the icd mutant, the ΔCUO mutant and the ΔCUO icd mutant. The ΔCUO 
mutant had a growth curve nearly identical to the wild type and the ΔCUO icd mutant 
had a growth curve that was nearly identical to the icd mutant indicating that the presence 
of the CUOs did not enable the NB10Sm icd mutant to reach to a wild type cell density 
after 24 h. 
icd mutant is as virulent as the wild type against juvenile rainbow trout. To 
determine if the NB10Sm icd mutant would be as virulent as the wild type (NB10Sm), 10 
juvenile rainbow trout were challenged via immersion at a dose of between 6.5×106 
CFU/ml to 9.4×106 CFU/ml (Table 4). Although it took seven days for the icd mutant to 
cause 70% morality and five days for the wild type to cause 80% mortality, there was no 
statistically significant difference in virulence between the two strains (P= 0.30).  
sucA mutant, fumA mutant, and a ΔfrdA sdhC mutant grow to a final cell density in 
complex media lower than the wild type. It was previously proposed that a decreased 
final cell density in complex media resulting from a nutrient limitation in vitro could 
correlate to attenuation in virulence in vivo [11]. Since the NB10Sm icd mutant did not 
show either a decrease in final cell density or a loss of virulence, an additional ten central 
metabolism single and double mutants were created in the following genes: cra, gltA, 
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Δicd gltA, sucA, sucC, sdhC, ΔfrdA, ΔfrdA sdhC, and fumA (Table 1). Fig. 5A shows a 
typical growth curve of the wild type (NB10Sm) and various central metabolism mutants. 
Examination of the growth yield for the various mutant strains after 24 h by optical 
density shows that the sucA mutant (OD600 = 0.551), fumA mutant (OD600 = 0.618), and a 
ΔfrdA sdhC mutant (OD600 = 0.482) failed to grow to a wild type (OD600 = 1.08) cell 
density (Fig. 5B). The sucA mutant and the ΔfrdA sdhC mutant have a large standard 
deviation at the 24 h time point that could have resulted from the strains resolving the 
merodiploid present in the sucA or sdhC gene. Supplementary Fig. 3 demonstrates how 
this reversion to a wild type phenotype could occur when the insertional mutant strains 
are grown in the absence of the antibiotic chloramphenicol. 
Supplementing LB20 with additional nutrients restores growth of the ΔfrdA ΔsdhC 
mutant but not the ΔsucA mutant to wild type levels. Fig 6A shows the final cell 
density (OD600) of the wild type (NB10Sm), ΔfrdA ΔsdhC mutant and the ΔsucA mutant 
after growth for 24 h and 48 h in LB20. The deletion mutations were shown to be stable 
because the standard deviation between biological repeats was nearly nonexistent and 
there was no increase in growth between 24 h and 48 h. The two mutant strains were 
further screened via colony PCR using primers specific to the pJM1 plasmid to ensure the 
decreased growth yield did not result from loss of this plasmid (data not shown). Fig 6B 
shows the final cell density (OD600) of the wild type and the ΔfrdA ΔsdhC mutant grown 
in LB20 or LB20 supplemented with succinic acid (118 mM), gluconate (118 mM), 
malate (118 mM) or aspartate (118 mM). The data indicate that the addition of malate or 
aspartate increased the growth of the ΔfrdA ΔsdhC mutant to near wild type level. 
Although the ΔfrdA ΔsdhC mutant cannot convert succinate to fumarate, it is not 
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auxotrophic for any metabolite. Fig. 6C shows the 24 h cell density (OD600) of the wild 
type and ΔsucA mutant grown in LB20 or LB20 supplemented with lysine (118 mM) or 
DL-α, ɛ-diaminopimelic acid (118 mM) or lysine, DL-α, ɛ-diaminopimelic acid, and 
methionine (118 mM). The ΔsucA mutant is auxotrophic for the TCA cycle intermediate 
succinyl-CoA, a metabolite that is needed in diaminopimelic acid, lysine and methionine 
biosynthesis [40]. The addition of lysine, DL-α, ɛ-diaminopimelic acid and methionine to 
LB20 did not restore the growth of the ΔsucA mutant to a wild type cell density and 
indicates that the cells are either unable to import lysine or DL-α, ɛ-diaminopimelic acid 
or methionine or the cells require metabolites upstream of diaminopimelic acid in the 
biosynthetic pathway of lysine and the enzymes involved in this pathway cannot run in 
reverse. Interestingly, the addition of lysine and DAP actually caused the wild type to 
grow to a lower cell density, indicating that these cells do not favor these metabolites for 
growth.  
The ΔsucA mutant and the ΔfrdA ΔsdhC mutant grow to a lower cell density 
compared to the wild type in various types of complex media. The final cell densities 
(CFU/ml) of the wild type (NB10Sm), ΔsucA mutant and the ΔfrdA ΔsdhC mutant were 
determined after 24 h of growth in four forms of complex media: LB20, NSSM, Spleen 
extract medium, and NSSSkM (Table 6). In all forms of complex media, the ΔsucA 
mutant grew to the lowest cell density followed by the ΔfrdA ΔsdhC mutant.  
All mutants exhibited either same or lower expression levels of the three hemolysin 
genes compared to wild type. Vah1, RtxA, and Plp are three hemolysins secreted by V. 
anguillarum M93Sm that have been characterized and determined to be responsible for 
the hemolytic/cytolytic activity against fish erythrocytes, leukocyte and epithelial cells [7, 
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9, 41] and unpublished data]. It is unknown how these hemolysins contribute to the 
virulence of V. anguillarum NB10Sm. The expression of vah1, rtxA and plp during 
exponential phase was tested to determine whether mutations in metabolism could affect 
the expression of these hemolysin genes (Fig. 7A). rtxA was the most highly expressed 
(>4.6×103 copies/10 ng RNA) of the three hemolysins in NB10Sm and there was no 
statistically significant difference between the wild type (NB10Sm) and the two mutants 
(ΔsucA and ΔfrdA ΔsdhC). The mutants have a decrease in expression in both plp and 
vah1 compared to the wild type. However, these genes were expressed at the limit of 
detection by qRT-PCR. In the wild type, there were <30 copies/10 ng RNA for plp and 
<10 copies/10 ng RNA for vah1. 
All mutants exhibited lower levels of empA metalloprotease gene expression 
compared to wild type. It has previously been demonstrated that V. anguillarum NB10 
empA metalloprotease mutants are slightly attenuated in virulence and that empA 
expression is dependent upon RpoS and, therefore, highly expressed during stationary 
phase [6, 42, 43]. The expression of empA during stationary phase was tested to 
determine whether mutations in metabolism could affect the expression of this gene (Fig. 
7B). There was a ~3000-fold decrease in the expression of empA in the ΔsucA mutant and 
a 23-fold decease in the ΔfrdA ΔsdhC mutant compared to the wild type (NB10Sm). Both 
decreases in expression were statistically significant (P = 0.008 and P = 0.01 
respectively). The data indicate that mutations in central metabolism can cause a decrease 
in the expression of the metalloprotease empA. 
ΔsucA mutant and the ΔfrdA ΔsdhC mutant are as virulent as the wild type against 
juvenile rainbow trout. To determine if the ΔsucA mutant and the ΔfrdA ΔsdhC mutant 
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would be as virulent as the wild type (NB10Sm), 5 juvenile rainbow trout were 
challenged via immersion at a dose of between 1.0×106 CFU/ml to 4.0×106 CFU/ml 
(Table 7). There was no statistically significant difference in mortality between fish 
challenged with the wild type (100%) and the ΔsucA mutant (100%) (P= 0.39) or ΔfrdA 
ΔsdhC mutant (100%) (P= 0.65). The data once again indicate that central metabolism 
mutants that have a lowered final cell density due to a starvation of a nutrient will not 
necessarily be attenuated in virulence.  
Discussion 
 A V. anguillarum M93Sm icd mutant (O2α serotype) was previously shown to be 
attenuated in virulence and elicit an immunoprotective response in juvenile rainbow trout 
[11]. Though, V. anguillarum is an extracellular pathogen, the attenuation was thought to 
have resulted from the inability of the mutant to synthesize α-ketoglutarate and its amino 
acid derivatives (i.e. glutamate and glutamine). Subsequently, we demonstrated that a 
M93Sm ΔgltA mutant, also auxotrophic for glutamate, exhibited no reduction in 
virulence in vivo. Unlike the previously reported intracellular pathogens, the attenuation 
in virulence of the icd mutant is likely to involve more than just a simple nutrient 
starvation [12-27] [Spinard, EJ et al, in preparation, chapter 2 of this manuscript 2017]. 
Regardless of the cause of the attenuation of the M93Sm icd mutant, it was still 
immunoprotective and has potential as a live cell vaccine against vibriosis. V. 
anguillarum vaccines must be multivalent in order to fully protect against vibriosis 
caused by all V. anguillarum serotypes (O1, O2, O3) implicated in disease [30]. 
Accordingly, this study originally sought to create a live attenuated O1 serotype strain by 
mutating icd in V. anguillarum NB10Sm. The NB10Sm icd mutant (the insertional 
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mutant and the deletion mutant) did not show the cell density limitation previously 
observed in the M93Sm icd mutant in complex media (Fig. 2) nor was it reduced in 
virulence against juvenile rainbow trout (Table 4) [11]. The NB10Sm icd mutant (ES920 
and ES926) did have a longer generation time than the wild type during mid and late 
exponential growth that was shortened by the addition of gluconate or glutamate to LB20. 
The data suggest that the decrease in growth rate of the NB10Sm icd mutant (ES920) 
occurs because the cells are required to utilize unfavorable metabolites or perform 
energetically unfavorable reactions during the mid and late exponential growth phase that 
can be alleviated by the addition of an extra energy source (gluconate) or metabolite that 
cannot be synthesized (glutamate). It is not clear why the V. anguillarum NB10Sm icd 
mutant is not starved for α-ketoglutarate like the M93Sm icd mutant. One explanation 
could be linked to the higher expression levels of the empA metalloprotease in V. 
anguillarum NB10 compared to V. anguillarum M93Sm in noninduced (LB20) 
conditions [6]. LB20 is composed of yeast extract and tryptone (both of which are 
composed of peptides of varying sizes), although bacteria can only utilize peptides that 
are six amino acids in size or smaller [44, 45]. The increase in expression of empA could 
allow the NB10Sm icd mutant (ES920) to more efficiently break down and utilize 
proteins and large sized peptides than M93Sm, preventing the cells from being starved 
for glutamate.  
 Since the NB10Sm icd mutant (ES920) was not attenuated in virulence and did 
not have a final cell density limit that was lower than the wild type after 24 h of growth in 
complex media, additional central metabolism mutants and double mutants were 
constructed (Table 1). Mutations in fumA, sucA or ΔfrdA sdhC caused reductions in the 
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final cell density (Fig. 5). Focus was placed on the sucA mutant and the ΔfrdA sdhC 
mutant and deletion mutants were constructed for each strain to prevent the mutants from 
spontaneously resolving the merodiploid (a phenomenon that was previously exploited to 
create the icd revertant strain [11]). The ΔfrdA ΔsdhC mutant can run the reductive and 
oxidative branch of the TCA cycle to synthesize any intermediate and accordingly, is not 
auxotrophic for any metabolite when it is grown with glucose as the only carbon source. 
However, the data suggest that the cells favor metabolites that feed into the TCA cycle at 
α-ketoglutarate such as glutamate and glutamine. Since the TCA cycle can only run α-
ketoglutarate to succinate (the reaction catalyzed by icd is nonreversible), the cells are 
starved for the amino acid aspartate. The growth limitation of the ΔsucA mutant was not 
fully characterized but is presumed to have resulted from the inability of the cells to 
synthesize succinyl-CoA, a metabolite utilized in the biosynthetic pathways for the 
production of diaminopimelic acid, lysine and methionine [40]. The initial hypothesized 
route of infection for V. anguillarum NB10Sm is through the skin, gills or anus of the fish 
where it enters the circulatory system and accumulates in the spleen [4, 5]. Accordingly, 
the final cell densities of the ΔsucA mutant and ΔfrdA ΔsdhC mutant were determined in 
media that represent early infection (NSSM and NSSSkM) and mid-infection (spleen 
extract medium). In all forms of complex media (including LB20 as a control) the ΔsucA 
mutant grew to the lowest cell density, followed by the ΔfrdA ΔsdhC mutant (Table 6). 
The data suggests that, even under ideal conditions at each point of the infection process, 
the mutants could be starved for essential metabolites in vivo. However, the infection 
experiments (Table 7) demonstrate that the starvation does not correlate to a loss of 
virulence in vivo (discussed below). 
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 The expression of the virulence factors (rtxA, plp, vah1, empA) were examined in 
the ΔsucA mutant and ΔfrdA ΔsdhC mutant and compared to the wild type (Fig. 7). NB10 
has been previously been shown to be non-hemolytic on blood agar, presumably from the 
hemolysins being degraded by EmpA before they can lyse the red blood cells [9]. This 
study expands upon this explanation and shows that the actual expression levels of the 
hemolysins is much lower in NB10Sm compared to M93Sm. Expression of rtxA during 
log phase was relatively similar between the wild type and the mutants, although a 
decrease in expression was observed for plp and vah1 (Fig. 7). This decrease was not 
believed to be relevant since the expression of plp and vah1 was very low in the wild type 
(28 and 6.5 copies per 10 ng of total RNA, respectively). It has previously been shown 
that a V. anguillarum M93Sm rtxA mutant is avirulent [7]. It is not known how rtxA 
contributes to the virulence of V. anguillarum NB10Sm especially since the RtxA of 
M93Sm and NB10Sm have different effector domains [46]. This study demonstrates that 
the expression of rtxA is 127-fold lower than in M93Sm [Spinard, EJ et al, in preparation, 
chapter 2 of this manuscript]. Yet, the expression of NB10Sm rtxA was still 160-fold 
higher than the expression of NB10Sm plp suggesting that it could be important for the 
infection process of NB10Sm. Expression of the metalloprotease empA was examined 
during stationary phase. empA has been shown to be nonessential for the virulence of V. 
anguillarum NB10 [42, 47]. It has previously been demonstrated that the expression of 
empA is cell density dependent [6]. Accordingly, the ΔsucA mutant had the lowest final 
cell density (13% of the wild type) and the lowest expression level of empA (0.03% of the 
wild type). The transcript of VanT, the transcriptional activator of empA, is stabilized by 
the sigma factor RpoS [43, 47]. Alternatively, the decrease in expression of empA in the 
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mutants could have resulted from a decrease in expression of RpoS. 
 Regardless of the lowered cell density limit and the decrease in empA production, 
both the ΔsucA mutant and ΔfrdA ΔsdhC mutant were as virulent as the wild type in 
juvenile rainbow trout (Table 7). The metabolite starvation that prevents the mutants 
from reaching a wild type growth yield in vitro does not prevent the cells from reaching 
the threshold needed to cause disease in vivo. Accordingly, the approach that was used in 
this study to find attenuated strains, screening central metabolism mutants that grow to a 
lower cell density than the wild type in vitro, was unsuccessful probably because V. 
anguillarum is an extracellular pathogen that grows in the nutrient rich mucus of the skin 
or intestines. Still, nutrient starvation must affect the infection process of V. anguillarum 
and contribute to attenuation of the previously reported M93Sm icd mutant (decreased 
final cell density compared to the wild type). If it did not, it would have been expected 
that the NB10Sm icd mutant (same final cell density as the wild type) would have been 
attenuated. Yet, there must be other unknown factors besides nutrient starvation that are 
contributing to the reduction of virulence seen in V. anguillarum M93Sm icd mutant or 
else the previously reported M93Sm ΔgltA mutant, that experiences the same starvation 
for glutamate as the icd mutant, would have been attenuated. Further studies must be 
performed with the M93Sm icd mutant to fully understand the cause of attenuation.  
Conclusions 
 Multiple central metabolism mutants and double mutants were constructed in V. 
anguillarum NB10Sm. Unlike the previously described V. anguillarum M93Sm icd 
mutant, the NB10Sm icd mutant was as virulent as the wild type. Although both the 
ΔsucA mutant and ΔfrdA ΔsdhC mutant grew to lower cell densities than the wild type in 
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several forms of complex media and had large and significant decreases in expression of 
the empA metalloprotease, neither strain was attenuated in virulence. Compared to plp 
and vah1, there was higher expression in the gene encoding the MARTX toxin rtxA, 
suggesting that rtxA may contribute to the virulence of NB10Sm. The data demonstrate 
that strain specific phenotypes may result even if mutations are made in the same highly 
conserved gene.  
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Table 1. Bacterial strains and plasmids used in this study 
Strain or 
plasmid 
Description Reference 
 
V. anguillarum 
strains 
  
NB10Sm Spontaneous Sm
r
 mutant of NB10 (serotype O1) [42] 
SM920 Sm
r
 Cm
r;
 icd insertional mutant This study 
ES926 Sm
r
 Km
r
; icd allelic exchange mutant This study 
ES926.990 
Sm
r
 Cm
r
 Km
r
; icd allelic exchange, gltA insertional double 
mutant 
This study 
ES930 Sm
r
 Cm
r;
 cra insertional mutant This study 
ES940 Sm
r
 Cm
r;
 sucA insertional mutant This study 
ES946 Sm
r
 Km
r
; sucA allelic exchange mutant This study 
ES950 Sm
r
 Cm
r;
 sucC insertional mutant This study 
ES960 Sm
r
 Cm
r;
 sdhC insertional mutant This study 
ES970 Sm
r
 Cm
r;
 fumA insertional mutant This study 
ES985 Smr Cm
r
 Km
r
; frdA insertional mutant This study 
ES986 Sm
r
 Km
r
; frdA allelic exchange mutant This study 
ES986.966 
Sm
r
 Km
r
; frdA allelic exchange, sdhC allelic exchange 
double mutant 
This study 
ES990 Sm
r
 Cm
r;
 gltA insertional mutant This study 
ES2546 Sm
r
 Km
r
; CUO allelic exchange mutant This study 
ES2546.920 
Sm
r
 Cm
r
 Km
r
; CUO allelic exchange icd insertional double 
mutant 
This study 
E. coli strains 
  
Sm10 thi thr leu tonA lacY supE recA RP4-2-Tc::Mu::Km (λ pir) [48] 
S100 Km
r
; Sm10 containing plasmid pNQ705-1 [49] 
Q925 Km
r
 Cm
r
; Sm10 containing plasmid pDM4-icd This study 
Q420 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-icd [11] 
Q440 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-sucA [11] 
Q450 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-sucC [11] 
Q460 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-sdhC [11] 
Q470 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-fumA [11] 
Q430 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-cra [11] 
Q990 Km
r
 Cm
r
; Sm10 containing plasmid pNQ705-gltA This study 
Q945 Km
r
 Cm
r
; Sm10 containing plasmid pDM4-sucA This study 
Q2545 Km
r
 Cm
r
; Sm10 containing plasmid pDM4-CUO This study 
Q985 Km
r
 Cm
r
; Sm10 containing plasmid pDM4-frdA This study 
Q965 Km
r
 Cm
r
; Sm10 containing plasmid pDM4-sdhC This study 
Plasmid 
  
pNQ705-1 Cm
r
; suicide vector with R6K origin [49] 
pDM4 Cm
r
 Km
r
 SacBC; suicide vector [35] 
pNQ705-gltA Cm
r
; For gltA insertional mutant This study 
pNQ705-icd Cm
r
; For icd insertional mutant [14] 
pNQ705-sucA Cm
r
; For sucA insertional mutant [14] 
pNQ705-sucC Cm
r
; For sucC insertional mutant [14] 
pNQ705-sdhC Cm
r
; For sdhC insertional mutant [14] 
pNQ705-fumA Cm
r
; For fumA insertional mutant [14] 
pNQ705-cra Cm
r
; For cra insertional mutant [14] 
pDM4-icd Cm
r
 Km
r
 SacBC; For icd deletion mutant This study 
pDM4-sucA Cm
r
 Km
r
 SacBC; For sucA deletion mutant This study 
pDM4-CUO Cm
r
 Km
r
 SacBC; For CUO deletion mutant This study 
pDM4-sdhC Cm
r
 SacBC; For sdhC deletion mutant This study 
 
117 
 
 
Table 2. Primers used in this study. 
Primer Sequence (5' to 3')1, 2 Description Reference 
pr31 GGTGAGCTCTATTCTTTATTGCCGATTATC For icd insertional mutant, forward, SacI [14] 
pr32 AAATCTAGAGTAAGTCGCTTTAATCGCTTC For icd insertional mutant, reverse, XbaI [14] 
pr50 AAAGAGCTCGTGATCCAGATGTCGATGCTA For sucA insertional mutant, forward, SacI [14] 
pr51 GGTTCTAGAGTTCAGTGTCGATAATGTGCA For sucA insertional mutant, reverse, XbaI [14] 
pr52 AAAGAGCTCGGTCGGATTAGTACAGCGAAG For sucC insertional mutant, forward, SacI [14] 
pr53 GGTTCTAGACTTTTTCAATTTCCACGCCGC For sucC insertional mutant, reverse, XbaI [14] 
pr54 AAAGAGCTCATGTTCGTTGCGGTCGGAATT For sdhC insertional mutant, forward, SacI [14] 
pr55 GGTTCTAGATCCAACTCTTCAAAGTGGCCC For sdhC insertional mutant, reverse, XbaI [14] 
pr56 GGTGAGCTCTCCTTGCACCATATTGATATG For fumA insertional mutant, forward, SacI  [14] 
pr57 GGGTCTAGAAGGCTTATCATCGAGAAGAGAG For fumA insertional mutant, reverse, XbaI [14] 
pm110 GGCGAGCTCTCGATGGCGAAAAAG For gltA insertional mutant, forward, SacI  This study 
pm111 GGCTCTAGAGCTCGTGGACCAT For gltA insertional mutant, reverse, XbaI This study 
pr33 AAAGAGCTCGCGGCGTGAGACTAAGGCATC For cra insertional mutant, forward, SacI [14] 
pr34 AAATCTAGACAATGGCAAAGCGCAGAAGTA For cra insertional mutant, reverse, XbaI [14] 
pm119 GCCGAGCTCTTTGTTCTGCTGGCTTTTTA For CUO 5' region, forward, sac1 This study 
pm120 GCCTCTAGAGGGATTTTGTTGGAAGTTGA For CUO 5' region, reverse xba1 This study 
pm121 GGCCTCGAGCTTAACTGTCATTCAGCCTC For CUO 3' region, forward, xhoI This study 
pm122 GGCGCTAGCGTGGAGGCTCTCTTTCTTAT For CUO 3' region, reverse nheI This study 
PmG-13 aatcccgggaGAGCTCCGTGAAAGAAAGAAAGTCAAGACCTG 
For sdhC 5' region, forward, Gibson 
assembly  This study 
PmG-14 aaatggcgACCCCAGACACTCGGTGTAG 
For sdhC 5' region, reverse, Gibson 
assembly  This study 
PmG-15 tctggggtCGCCATTTGCTGATGGACC 
For sdhC 3' region, forward, Gibson 
assembly  This study 
PmG-16 cgggtaacctGAGCTCTAAAACTGAAAGCACTGCTGTTGC 
For sdhC 3' region, reverse, Gibson 
assembly  This study 
pr68 TTAATTTCTAGATGATAATGGTGCGCGGCGATC For icd 5'region, reverse, xba1 This study 
pr69 TAATAACTCGAGAAAGCACGGCGCATTTGATCC For icd 3' region, forward, xho1 This study 
pr70NheI ACTGCTGCTAGCGAATAGATCCGTGAGGTAATC For icd 3' region, reverse, nhe1 This study 
pm64suc GCACTCGAGTCTGGTTTGTTATCGCCGTC For sucA 3' region, forward, xho1 This study 
 pm65suc GTAGCTAGCGCGGATTCGCTTTCCATCAT For sucA 3' region, reverse, nhe1 This study 
pm76 GTAGAGCTCGGAGGCTCAGCAGCAGTTAT For frdA 5' region, forward, sacI This study 
pm77 GATTCTAGAGAAGAGGGTGTGCAGCATGT For frdA 5' region, reverse, xbaI This study 
pm78 CTACTCGAGTTCGCACTGAGATGGGTCAC For frdA 3' region, forward, xhoI This study 
pm79 GTTGCTAGCTCGATACTTGGAGCGGCATC For frdA 3' region, reverse, nheI This study 
pm38 CGGCTATCTAGAGAAAAGCTTGAACACGTAGAA For KanR forward, XbaI  
pm39 GCATTACTCGAGCGTTTCTGGGTGAGCAAAAAC For KanR reverse, xhoI  
vah1 F RT  GTTTGGTATGGAACACCGCTCAAG For vah1 qRT-PCR, forward Reference 
vah1 R RT GGCTCAACCTCTCCTTGTAACCAA For vah1 qRT-PCR, reverse Reference 
plp F RT CAGACGACCACCAGTAACCACTAA For plp qRT-PCR, forward Reference 
plp R RT GCAATCATGATGACCCAGCAACAG For plp qRT-PCR, reverse Reference 
Pm111 GGAAATTATTCCGCCGACGATGGA For rtxA qRT-PCR, forward Reference 
Pm112 GCCGATACCGTATCGTTACCTGAA For rtxA qRT-PCR, reverse Reference 
empA-qRT-PCR-
F 
TCAAATCTTCCGGTGGCTTACGTT For empA qRT-PCR, forward Reference 
empA-qRT-PCR-
R 
GCGCGATTAAACACACCACTTGAA For empA qRT-PCR, reverse Reference 
1lowercase sequences are designed to be homologous to flanking sequences 
2underlined sequences are designed to be restriction enzyme cut sites 
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Table 3. Generation times of various V. anguillarum strains grown in LB201 
Strain 
Early Exponential Phase 
(Minutes) 
Mid Exponential Phase 
(Minutes) 
Late Exponential Phase 
(Minutes) 
 
LB20 Gluconate Glutamate LB20 Gluconate Glutamate LB20 Gluconate Glutamate 
NB10Sm 55 65 74 98 84 84 105 99 102 
icd 
(ES920) 
55 63 68 108 76 83 107 97 101 
1Values calculated from data presented in Figure 2A and Figure 3 during exponential growth. 
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Table 4. Virulence of V. anguillarum strains in juvenile rainbow trout 
Strain 
Dosage 
(CFU/ml) 
Total 
Mortality 
No. of days until death (No. of fish / 
total) 
NB10Sm 7.2-9.4×106 80% 2 (6/10) 3 (5/10) 4 (6/10) 5 (8/10) 
icd (ES920) 6.5-6.9×106 70% 
2 (1/10) 3 (3/10) 4 (4/10) 5 (5/10) 7 
(7/10) 
NSS 
 
0% NA 
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Table 5. Generation times of various V. anguillarum strains grown in LB201 
Strain 
Early Exponential Phase 
(Minutes) 
Late Exponential Phase 
(Minutes) 
NB10Sm 55 102 
icd (ES920) 45 102 
gltA 51 100 
Δicd gltA 54 103 
cra 52 102 
sucA 55 115 
sucC 67 107 
sdhC 58 109 
fumA 57 108 
ΔfrdA 60 101 
ΔfrdA sdhC 58 113 
1Values calculated from data presented in Figure 5A during exponential growth. 
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Table 6. Final cell density (CFU/ml) of various V. anguillarum cultures grown for 24 h 
Strain CFU/ml in LB20 
CFU/ml in NSSM 
(200µg/ml) 
CFU/ml in Spleen 
CFU/ml in NSSSkM 
(200µg/ml) 
NB10Sm 7.8×109 (±1.1×109) 7.2×109 (±0.9×108) 1.5×108 (±0.2×108) 1.6×109 (±0.3×108) 
ΔsucA 1.0×109 (±0.9×109)** 4.6×108 (±2.7×108)** 1.2×107 (±0.8×107)** 
3.8×107 (±0.3×108)** 
ΔfrdA 
ΔsdhC 
2.2×109 (±0.6×109)* 2.5×109 (±1.2×109)* 7.7×107 (±0.5×107) 
2.2×108 (±0.3×108)** 
** statistically significant to wild type (P < 0.01), * statistically significant to wild type (P < 0.05) 
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Table 7. Virulence of V. anguillarum strains in juvenile rainbow trout 
Strain 
Dosage 
(CFU/ml) 
Total 
Mortality 
No. of days until death (No. of fish / total) 
NB10Sm 4×106 100% 2 (3/5) 3 (4/5) 4 (5/5) 
ΔsucA 3.5×106 100% 2 (1/5) 3 (4/5) 5 (5/5) 
ΔfrdA ΔsdhC 1.×106 100% 2 (4/5) 3 (5/5) 
NSS NA 0% NA 
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TABLE 8. Comparison of all mutant V. anguillarum strains 
Strain Information Growth Characteristics Gene Expression 
Virulent 
in 
rainbow 
trout 
Name Gene 
Mutation 
Type 
Parental 
Strain 
Growth 
Rate 
Final Growth Yield 
Auxotrophic rtxA plp vah1 prpC empA 
LB20 
3M + 
0.15% 
Glucose 
NSSM Spleen NSSSkM 
XM410 mdh ID M93Sm - + + ND ND ND ND + + + ND ND + 
XM420 icd ID M93Sm + - - - ND ND 
α-
ketoglutarate 
derivatives 
+ + + ND ND - 
XM430 cra ID M93Sm + + + ND ND ND ND + ++ + ND ND + 
XM440 sucA ID M93Sm - + - ND ND ND 
Succinyl 
CoA 
derivatives 
+ ++ ++ ND ND + 
XM450 sucC ID M93Sm - + + ND ND ND ND + ++ ++ ND ND + 
XM460 sdhC ID M93Sm - + + ND ND ND ND + ++ ++ ND ND + 
XM470 fumA ID M93Sm - + + ND ND ND ND + + ++ ND ND + 
ES422 icd NA XM420 + + + ND ND ND ND ND ND ND ND ND + 
ES496 gltA AE M93Sm + - ± - - ND 
α-
ketoglutarate 
derivatives 
+ + + + ND + 
ES3-2 
gltA, 
prpR 
AE, 
R66L 
M93Sm + - + - + ND 
α-
ketoglutarate 
derivatives 
ND ND ND ++ ND + 
ES496.6600 
gltA, 
prpC, 
prpR 
AE, AE, 
R66L 
M93Sm + - - - - ND 
α-
ketoglutarate 
derivatives 
ND ND ND ND ND + 
ES6600 prpC AE M93Sm + + + ND + ND ND ND ND ND ND ND + 
ES920 icd ID NB10Sm - + - ND ND ND 
α-
ketoglutarate 
derivatives 
ND ND ND ND ND + 
ES926 icd AE NB10Sm - + ND ND ND ND 
α-
ketoglutarate 
derivatives 
ND ND ND ND ND ND 
ES926.990 
icd, 
gltA 
AE, ID NB10Sm + + ND ND ND ND 
α-
ketoglutarate 
derivatives 
ND ND ND ND ND ND 
ES930 cra ID NB10Sm + + ND ND ND ND ND ND ND ND ND ND ND 
ES940 sucA ID NB10Sm - - ND ND ND ND 
succinyl 
CoA 
derivatives 
ND ND ND ND ND 
 
ND 
ES946 sucA ID NB10Sm ND - ND - - - 
succinyl 
CoA 
derivatives 
+ - - ND - + 
ES950 sucC ID NB10Sm - + ND ND ND ND ND ND ND ND ND ND ND 
ES960 sdhC ID NB10Sm - - ND ND ND ND ND ND ND ND ND ND ND 
ES970 fumA ID NB10Sm - - ND ND ND ND ND ND ND ND ND ND ND 
ES986 frdA AE NB10Sm + + ND ND ND ND ND ND ND ND ND ND ND 
ES986.960 
frdA, 
sdhC 
AE, ID NB10Sm - - ND ND ND ND aspartate ND ND ND ND ND ND 
ES986.966 
frdA, 
sdhC 
AE, AE NB10Sm ND - ND - + - aspartate + + -  - + 
ES990 gltA ID NB10Sm + + ND ND ND ND 
α-
ketoglutarate 
derivatives 
ND ND ND ND ND ND 
ES2546 CUOs AE NB10Sm + + ND ND ND ND ND ND ND ND ND ND ND 
ES2546.920 
CUOs 
icd 
AE, ID NB10Sm - + ND ND ND ND 
α-
ketoglutarate 
derivatives 
ND ND ND ND ND ND 
ID: Insertional Deletion (merodiploid capable of restoring to a wild type genotype) 
AE: Allelic Exchange 
NA: Not Applicable 
ND: Not Determined 
CUO: Citrate Utilization Operon 
+ Wild type level 
++ Greater than wild type 
- Less than Wild type 
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Figure Legends 
Figure 1. Embden-Meyerhoff-Parnas Pathway, TCA cycle, and metabolism of fructose. 
The arrows indicate the physiological directions of the reactions. The gene symbols of the 
enzyme for each reaction are listed beside the reaction. Boxed genes indicate the genes 
that were mutated in this study (Table 1). 
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Figure 2. Growth of V. anguillarum WT (NB10Sm) and the icd mutant (ES920) under 
various conditions. Growth curves of V. anguillarum strains NB10Sm and the icd mutant 
in LB20 at 27°C with shaking (200 rpm). At various time points after inoculation samples 
were taken for determination of optical density at 600 nm (OD600). The data are the 
average of two independent experiments. Error bars represent 1 standard deviation. B) 
Final cell densities (OD600) of V. anguillarum strains NB10Sm and the icd mutant after 24 
h of growth in 3M plus 0.15% glucose supplemented with or without 2 mM glutamate or 
2 mM glutamine. In each experiment cells grown overnight in LB20 were washed in NSS 
and used to inoculate the appropriate media. Cultures were incubated at 27
o
C in a shaking 
water bath (200 rpm) and at various time points after inoculation samples were taken for 
determination of optical density at 600 nm (OD600). 
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Figure 3. Growth of V. anguillarum WT (NB10Sm) and the icd mutant under various 
conditions. A) Growth curves of V. anguillarum NB10Sm (black) and the icd mutant 
(blue) in LB20 (dashed lines) or LB20 supplemented with 101.7 mM gluconate (solid 
lines). B) Growth curves of V. anguillarum NB10Sm (black) and the icd mutant (blue) in 
LB20 (dashed lines) or LB20 supplemented with 118 mM glutamate (solid lines). In each 
experiment cells grown overnight in LB20 were washed in NSS and used to inoculate the 
appropriate media. Cultures were incubated at 27
o
C in a shaking water bath (200 rpm) 
and at various time points after inoculation samples were taken for determination of 
optical density at 600 nm (OD600). The data are the average of two independent 
experiments. Different letters indicate statistical significance among groups (P < 0.05). 
Statistical analysis was based on data at 24 h. Error bars represent 1 standard deviation. 
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Figure 4. Growth curves of various V. anguillarum strains grown in LB20 at 27°C with 
shaking (200 rpm). At various time points after inoculation samples were taken for 
determination of optical density at 600 nm (OD600). The data are the average of two 
independent experiments. Error bars represent 1 standard deviation. 
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Figure 5. Growth of various V. anguillarum strains grown in LB20 at 27°C with shaking 
(200 rpm). A) Growth curve of various V. anguillarum strains. At various time points 
after inoculation samples were taken for determination of optical density at 600 nm 
(OD600). B) Examination of the 24 h time point from Figure 5A. The data are the average 
of two independent experiments. Between marked strains and NB10Sm: * P < 0.05 and 
*** P < 0.001. Error bars represent 1 standard deviation. 
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 Figure 6. Growth of V. anguillarum WT (NB10Sm) the ΔsucA mutant and the ΔfrdA 
ΔsdhC mutant under various conditions. A) Final cell densities (OD600) of V. anguillarum 
strains NB10Sm, the ΔsucA mutant and the ΔfrdA ΔsdhC mutant after 24 h or 48 h of 
growth in LB20. B) Final cell densities (OD600) of V. anguillarum strains NB10Sm and 
the ΔfrdA ΔsdhC mutant after growth for 24 h in LB20 with or without the addition of 
either succinic acid (118 mM), gluconate acid (118mM), malate acid (118 mM), or 
aspartate acid (118 mM). C) Final cell densities (OD600) of V. anguillarum strains 
NB10Sm and the ΔsucA mutant after 24 h of growth in LB20 with or without the addition 
of either lysine (118 mM) or DL-α, ɛ-Diaminopimelic acid. In each experiment cells 
grown overnight in LB20 were washed in NSS and used to inoculate the appropriate 
media. Cultures were incubated at 27
o
C in a shaking water bath (200 rpm) and at various 
time points after inoculation samples were taken for determination of optical density at 
600 nm (OD600). The data are the average of two independent experiments. Different 
letters indicate statistical significance among groups (P < 0.05). Between marked strains 
and NB10Sm grown in LB20: ** P < 0.01, *** P < 0.001 and **** P < 0.0001. Error 
bars represent 1 standard deviation. Error bars represent 1 standard deviation. 
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Figure 7. mRNA expression levels of various genes. A) Expression of vah1, plp, rtxA determined 
by qRT-PCR analysis of V. anguillarum wild-type (NB10Sm), the ΔsucA mutant and the 
ΔfrdA ΔsdhC mutant during logarithmic (Log)-phase growth. B) Expression of empA 
determined by qRT-PCR analysis of V. anguillarum wild-type (NB10Sm), the ΔsucA mutant 
and the ΔfrdA ΔsdhC mutant during stationary phase (Stat)-phase growth. The data presented 
are representative of two independent experiments. Each value is the average for six replicates. 
Between marked strains and NB10Sm: ** P < 0.01. Error bars represent 1 standard deviation. 
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 Figure S1. Cell density determined by viable count vs. OD600 of V. anguillarum 
NB10Sm. The line indicates linear regression. 
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Figure S2. Graphical representation of the CUO region (blue arrows) and flanking genes 
(green arrows) in the genomes of V. anguillarum A) NB10 and B) M93Sm. Yellow 
arrows represent open reading frames encoding hypothetical proteins. 
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Figure S3. Graphical representation of a suicide vector inserting into the sucA gene. A) 
First a crossover event occurs in the genome and the suicide vector inserts in the 5’ 
region of sucA. B) If the cells are grown without selection a second cross over event can 
occur that will C) resolve the merodiploid and restore the wild type sucA. Figure not 
drawn to scale. 
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Figure S4. Growth curves of V. anguillarum M93Sm, NB10Sm, and their derived icd 
mutant strains grown in LB20 at 27°C with shaking (200 rpm). At various time points 
after inoculation samples were taken for determination of optical density at 600 nm 
(OD600). The data are the average of two independent experiments. Error bars represent 1 
standard deviation. 
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Vibrio coralliilyticus RE22 is a causative agent of vibriosis in larval bivalves. We report 
the draft genome of V. coralliilyticus RE22 and describe additional virulence factors, 
which may provide insight into the mechanism of pathogenicity.  
Vibrio coralliilyticus RE22 (formally Vibrio tubiashii RE22) is a marine pathogen 
and a causative agent of vibriosis in larval bivalves (1). Disease is characterized by high 
mortality rates leading to severe loss of production in shellfish hatcheries (2-4). 
Currently, only two proteases (VtpA and VtpB) and one hemolysin (VthA) have been 
characterized in RE22 (5-7). To better understand mechanisms of pathogenicity, it is 
necessary to discover additional potential virulence factors. Here we announce the draft 
genome sequence of V. coralliilyticus RE22 and selectively describe some potential 
virulence factors.  
V. coralliilyticus RE22Sm (a spontaneous mutant resistant to streptomycin) was 
grown overnight in yeast-peptone broth supplemented with 3% NaCl (YP30) at 27°C in a 
shaking water bath. Genomic DNA was isolated using the Wizard Genomic DNA 
Purification kit (Promega) according to the manufacturer’s instructions except DNA was 
resuspended into 100 μl of a 2mM Tris-HCl, pH 8solution. DNA was sequenced at the 
Rhode Island Genomics Sequencing Center using an Illumina MiSeq Sequencer. Reads 
were trimmed using the CLC Genomics Workbench (v8.0.1) for quality, ambiguous base 
pairs, adapters, duplicates and size resulting in 7,602,646 paired-end and mate-paired 
reads averaging 235.84 bp in size. Reads were assembled using the de novo assembly 
algorithm of CLC Genomics Workbench and SPAdes Genomic Assembler (v3.1.1) (8). 
Contigs with an average coverage above 110 reads were joined using the CLC Microbial 
Genome Finishing module using V. coralliilyticus OCN014 as a reference genome. In 
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total, the draft genome is composed of five contigs. Three contigs totaling 3.46 Mbp and 
having an average G+C content of 46% mapped to chromosome 1 of V. coralliilyticus 
OCN014. The complete chromosome 2 is represented by one 1.90 Mbp contig with a 
G+C content of 45%. A megaplasmid is represented by one 0.32 Mbp contig with a G+C 
content of 50%. The draft genome was annotated using Rapid Annotation using 
Subsystem Technology (RAST) and resulted in 5234 open reading frames (9-11). 
The genome of V. coralliilyticus RE22 encodes two extracellular metalloproteases 
besides the previously described vtpA and vtpB. One protease shows similarity to epp in 
Vibrio anguillarum (12) while the other contains a domain conserved in M4 family of 
metalloproteases (13-17). In addition to vthA, three putative hemolysin/cytolysin genes 
were discovered. A putative MARTX toxin operon encoding three T1SS transport 
proteins, a MARTX toxin, and a hypothetical protein is on the megaplasmid. Unlike 
typical MARTX toxin gene clusters, the transporter genes are not transcribed divergently 
from the MARTX toxin (18). Instead they seem to be in the MARTX operon, upstream 
of the MARTX toxin gene. Unlike most MARTX toxin gene clusters, no rtxC 
(acyltransferase) is present in the operon. Additional putative hemolysins include a 
phospholipase/hemolysin located on chromosome 2 that shows similarity to plp in V. 
anguillarum (19) and a hemolysin annotated as hlyA located on chromosome 1 that 
shows similarity to vah1 in V. anguillarum (20). 
This Whole Genome Shotgun project has been deposited in DDBJ/ENA/GenBank 
under the accession no. LGLS00000000. The version described in this paper is the first 
version, LGLS01000000. 
 
156 
 
Funding information. This work was supported by an award from the Rhode Island 
Science and Technology Council to DRN and DR. This research is based in part upon 
work conducted using the Rhode Island Genomics and Sequencing Center, which is 
supported in part by the National Science Foundation under EPSCoR Grants Nos. 
0554548 & EPS-1004057. The funders had no role in study design, data collection and 
interpretation, or the decision to submit the work for publication.  
Acknowledgements. We thank Ralph Elston and Hiroaki Hasegawa for providing us 
with the Vibrio coralliilyticus RE22 strain.  
 
References. 
1. Wilson B, Muirhead A, Bazanella M, Huete-Stauffer C, Vezzulli L, Bourne 
DG. 2013. An improved detection and quantification method for the coral 
pathogen Vibrio coralliilyticus. PLoS One 8:e81800. 
2. Estes RM, Friedman CS, Elston RA, Herwig RP. 2004. Pathogenicity testing 
of shellfish hatchery bacterial isolates on Pacific oyster Crassostrea gigas larvae. 
Dis Aquat Organ 58:223-230. 
3. Elston RA, Hasegawa H, Humphrey KL, Polyak IK, Hase CC. 2008. Re-
emergence of Vibrio tubiashii in bivalve shellfish aquaculture: severity, 
environmental drivers, geographic extent and management. Dis Aquat Organ 
82:119-134. 
4. Sindermann CJ, Lightner DV. 1988. Disease diagnosis and control in North 
American marine aquaculture, 2nd, rev. ed. Elsevier, Amsterdam ; New York. 
157 
 
5. Hasegawa H, Hase CC. 2009. TetR-type transcriptional regulator VtpR functions 
as a global regulator in Vibrio tubiashii. Appl Environ Microbiol 75:7602-7609. 
6. Hasegawa H, Lind EJ, Boin MA, Hase CC. 2008. The extracellular 
metalloprotease of Vibrio tubiashii is a major virulence factor for pacific oyster 
(Crassostrea gigas) larvae. Appl Environ Microbiol 74:4101-4110. 
7. Hasegawa H, Hase CC. 2009. The extracellular metalloprotease of Vibrio 
tubiashii directly inhibits its extracellular haemolysin. Microbiology 155:2296-
2305. 
8. Nurk S, Bankevich A, Antipov D, Gurevich AA, Korobeynikov A, Lapidus A, 
Prjibelski AD, Pyshkin A, Sirotkin A, Sirotkin Y, Stepanauskas R, 
Clingenpeel SR, Woyke T, McLean JS, Lasken R, Tesler G, Alekseyev MA, 
Pevzner PA. 2013. Assembling single-cell genomes and mini-metagenomes from 
chimeric MDA products. J Comput Biol 20:714-737. 
9. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, 
Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, 
Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, 
Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O. 2008. The 
RAST Server: rapid annotations using subsystems technology. BMC Genomics 
9:75. 
10. Brettin T, Davis JJ, Disz T, Edwards RA, Gerdes S, Olsen GJ, Olson R, 
Overbeek R, Parrello B, Pusch GD, Shukla M, Thomason JA, 3rd, Stevens R, 
Vonstein V, Wattam AR, Xia F. 2015. RASTtk: a modular and extensible 
158 
 
implementation of the RAST algorithm for building custom annotation pipelines 
and annotating batches of genomes. Sci Rep 5:8365. 
11. Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, Edwards RA, 
Gerdes S, Parrello B, Shukla M, Vonstein V, Wattam AR, Xia F, Stevens R. 
2014. The SEED and the Rapid Annotation of microbial genomes using 
Subsystems Technology (RAST). Nucleic Acids Res 42:D206-214. 
12. Varina M, Denkin SM, Staroscik AM, Nelson DR. 2008. Identification and 
characterization of Epp, the secreted processing protease for the Vibrio 
anguillarum EmpA metalloprotease. J Bacteriol 190:6589-6597. 
13. Adekoya OA, Sylte I. 2009. The thermolysin family (M4) of enzymes: 
therapeutic and biotechnological potential. Chem Biol Drug Des 73:7-16. 
14. Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott 
C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, He S, Hurwitz DI, 
Jackson JD, Ke Z, Lanczycki CJ, Liebert CA, Liu C, Lu F, Lu S, Marchler 
GH, Mullokandov M, Song JS, Tasneem A, Thanki N, Yamashita RA, Zhang 
D, Zhang N, Bryant SH. 2009. CDD: specific functional annotation with the 
Conserved Domain Database. Nucleic Acids Res 37:D205-210. 
15. Marchler-Bauer A, Bryant SH. 2004. CD-Search: protein domain annotations 
on the fly. Nucleic Acids Res 32:W327-331. 
16. Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, 
Geer RC, He J, Gwadz M, Hurwitz DI, Lanczycki CJ, Lu F, Marchler GH, 
Song JS, Thanki N, Wang Z, Yamashita RA, Zhang D, Zheng C, Bryant SH. 
159 
 
2015. CDD: NCBI's conserved domain database. Nucleic Acids Res 43:D222-
226. 
17. Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, 
DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, 
Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Lu F, Marchler GH, 
Mullokandov M, Omelchenko MV, Robertson CL, Song JS, Thanki N, 
Yamashita RA, Zhang D, Zhang N, Zheng C, Bryant SH. 2011. CDD: a 
Conserved Domain Database for the functional annotation of proteins. Nucleic 
Acids Res 39:D225-229. 
18. Satchell KJ. 2007. MARTX, multifunctional autoprocessing repeats-in-toxin 
toxins. Infect Immun 75:5079-5084. 
19. Li L, Mou X, Nelson DR. 2013. Characterization of Plp, a phosphatidylcholine-
specific phospholipase and hemolysin of Vibrio anguillarum. BMC Microbiol 
13:271. 
20. Rock JL, Nelson DR. 2006. Identification and characterization of a hemolysin 
gene cluster in Vibrio anguillarum. Infect Immun 74:2777-2786. 
  
160 
 
Appendix-II 
Published July 28th 2016 in Genome Announcements 
Draft genome sequence of the emerging bivalve pathogen Vibrio tubiashii subsp. 
europaeus. 
 
Edward J. Spinarda, Javier Dubertb, David R. Nelsona#, Susana Prado, Marta Gomez-
Chiarric, Juan L. Barjab. 
 
aDepartment of Cell and Molecular Biology, University of Rhode Island, Kingston, 
Rhode Island, 02881 United States 
bDepartamento de Microbiología y Parasitología, CIBUS–Facultad de Biología, 
Universidade de Santiago de Compostela, Santiago de Compostela, 15782 Spain.  
cDepartment of Fisheries, Animal and Veterinary Sciences, University of Rhode Island, 
Kingston, Rhode Island, 02881 United States 
 
Running title: Draft genome of Vibrio tubiashii subsp. europaeus. 
 
 
#Corresponding author:  
Address correspondence to David R. Nelson, dnelson@uri.edu 
161 
 
Vibrio tubiashii subsp. europaeus is a bivalve pathogen isolated during episodes of 
mortality affecting larval cultures in different shellfish hatcheries. Here we announce the 
draft genome of the type strain PP-638 and describe potential virulence factors, which 
may provide insight into the mechanism of pathogenicity. 
 
 Vibrio tubiashii subsp. europaeus is an emerging bivalve pathogen identified 
recently as the etiological agent responsible of larval and spat mortalities in clam, oyster 
and abalone cultures detected in Spanish and French hatcheries (1, 2). This pathogen is a 
causative agent of vibriosis inducing mass mortalities and important economic losses, 
representing the main bottleneck for the production process in shellfish aquaculture (1, 
2). 
V. tubiashii subsp. europaeus PP-638T (= CECT 8136T= DSM 27349T) was 
originally isolated from seawater in a culture tank of flat oyster (Ostrea edulis) during an 
episode of larval mortality detected in a shellfish hatchery (Galicia, NW Spain) (1). DNA 
was isolated from V. tubiashii subsp. europaeus PP-638T grown up overnight in YP30 
using the Wizard Genomic DNA Purification kit (Promega) following the manufacturer’s 
instructions except DNA was resuspended in 2mM Tris-HCl Buffer (Bio Basic). 
Genomic DNA was sequenced using an Illumina MiSeq at the Rhode Island Genomics 
and Sequencing Center at the University of Rhode Island. Reads were trimmed using the 
CLC Genomics Workbench (v8.5.1) for quality, ambiguous nucleotides and adapters. 
2,943,708 paired-end and 3,234,516 mate-paired reads providing 199× coverage were 
assembled using Spades (v3.1.1) using the default parameters (1). Contigs were filter 
based on 34× coverage and 4000 bp length resulting in ten contigs with an N50 of 
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1,788,614 and an average G + C content of 45.37%. The assembly was mapped to Vibrio 
tubiashii ATCC 19109 using the CLC Microbial Genome Finishing module and resulted 
in six contigs mapping to chromosome 1, one complete contig representing chromosome 
2, one complete contig representing the p251-like megaplasmid and one contig mapping 
to the p57-like plasmid (2). One 4,885 bp contig did not map to the reference genome. 
The draft genome was submitted to Rapid Annotations using Subsystems Technology 
(RAST) for annotation resulting in 5157 open reading frames (3-5). 
 Encoded on chromosome 2 of the V. tubiashii subsp. europaeus PP-638T genome 
is a putative metalloprotease that has a 75% similarity to VtpA found in Vibrio 
coralliilyticus RE22 (6). Another protease that has a 71% similarity to Epp in Vibrio 
anguillarum M93Sm is encoded on chromosome 2 (7). There are three putative 
hemolysins and phospholipases encoded in the genome. One hemolysin located on 
chromosome 2 has a 67% similarity to Plp in V. anguillarum M93Sm (8, 9). In V. 
anguillarum M93Sm, plp is divergently transcribed from the pore-forming 
hemolysin/cytolysin vah1 (9). In V. tubiashii subsp. europaeus PP-638T, the Plp homolog 
is also divergently transcribed away from a pore-forming cytolysin, though it has a 42% 
similarity to aerolysin in Aeromonas eucrenophila, not vah1 (NCBI Reference Sequence: 
WP_042642875.1). The genome encodes two secretion systems (T3SS and T6SS) that 
are used to deliver effecter molecules directly into the host. The T3SS secreted virulence 
factor has a domain that is similar to the GTPase-activating domain found on YopE from 
Yersinia pestis (10-14). While the T6SS structural components are encoded on the p251-
like megaplasmid, the protein responsible for forming the puncturing tip of the T6SS 
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secretion system, VgrG, appears to be encoded by two genes. One VgrG-encoding gene 
is on Chromosome 1 and the second is on Chromosome 2.  
 
Nucleotide sequence accession numbers. This Whole Genome Shotgun project has 
been deposited in DDBJ/EMBL/GenBank under the accession number LUAX00000000. 
The version described in this paper is the first version LUAX01000000. 
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